carbapenems has been researched along with E coli Infections in 246 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (1.22) | 18.7374 |
| 1990's | 6 (2.44) | 18.2507 |
| 2000's | 22 (8.94) | 29.6817 |
| 2010's | 147 (59.76) | 24.3611 |
| 2020's | 68 (27.64) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, EW; Chen, S; Dong, N; Li, R; Liu, X; Ye, L | 1 |
| Akalın, H; Eser, ÖK; Gürpınar, Ö; Köksal, İ; Otlu, B; Özakın, C; Ünal, S; Zarakolu, P | 1 |
| Al-Mir, H; Drapeau, A; Haenni, M; Hamze, M; Madec, JY; Osman, M | 1 |
| Guo, L; Li, F; Li, X; Wang, L; Yang, J; Ye, K; Ye, L | 1 |
| Bertoncelli, A; Mazzariol, A; Righetti, V | 1 |
| Dong, H; Li, X; Liu, C; Ming, L; Xu, M | 1 |
| Enoki, Y; Hayashi, M; Igarashi, Y; Kojima, N; Liu, X; Matsumoto, K; Mizukami, Y; Morita, T; Nakamura, T; Taguchi, K; Takemura, W; Tashiro, S; Yokoyama, Y | 1 |
| Amolini, C; Boroni, G; Caruso, A; Corbellini, S; De Francesco, MA; Gurrieri, F; Mascherpa, M; Piccinelli, G; Scaltriti, E | 1 |
| Ali, A; Hasan, B; Hassan, B; Khan, AU; Mohsin, M; Swedberg, G | 1 |
| Li, Y; Wang, S; Zhang, R | 1 |
| Bakhtiar, A; Chong, CW; Khalid, KE; Khan, RA; Tan, SY | 1 |
| Allman, E; Blomberg, B; Goodman, RN; Hubbard, ATM; Kibwana, U; Langeland, N; Manyahi, J; Moyo, SJ; Roberts, AP | 1 |
| Neville, LF; Rendell, JT; Shalit, I; Warn, PA | 1 |
| Anaraki, S; Barry, D; Cherian, BP; Cole, K; Cummins, M; Didelot, X; Jauneikaite, E; Lasalle, F; Ledda, A; Manuel, R; Paul, J; Rosmarin, C; Shaw, LP; Stoesser, N; Turton, J; Wareham, D | 1 |
| Dong, N; Guo, X; Hu, X; Jin, L; Li, P; Lin, Y; Qiu, S; Song, H; Sun, Y; Wang, X; Xiang, Y; Yang, L; Zhang, C; Zhang, L | 1 |
| Al-Bayati, M; Samarasinghe, S | 1 |
| Deng, G; Feng, M; Gao, Y; Hao, F; He, P; Liu, X; Liu, Y; Miao, Q; Zhang, N; Zhang, Z; Zhao, L; Zhu, J | 1 |
| Chen, J; Huang, XB; Lv, Y; Wang, C; Wei, DQ; Wu, JY; Xiang, Q | 1 |
| Bauer, MJ; Flora, MS; Forde, BM; Habib, ZH; Harris, P; Islam, K; Roberts, JA; Shirin, T; Sime, FB; Wallis, SC | 1 |
| Vital, PG; Zara, ES | 1 |
| Doi, Y; Enokida, T; Harada, S; Hayama, B; Hoashi, K; Ohkushi, D; Sakurai, A; Suzuki, M; Takeda, K; Takehana, K | 1 |
| Akeda, Y; Hamada, S; Iida, T; Matsumoto, Y; Motooka, D; Sakamoto, N; Sugawara, Y | 1 |
| Deligios, M; Fiamma, M; Paglietti, B; Rubino, S; Sacarlal, J; Santona, A; Simbine, SE; Sumbana, JJ; Taviani, E; Zimba, T | 1 |
| Courtois, R; Danneels, P; Dubée, V; Eveillard, M; Kempf, M; Mahieu, R; Quinqueneau, C; Rihet, C; Vannier, C | 1 |
| Guzmán-Cedillo, AE; Jang, BH; Kang, JH; Kwon, S; Lee, MS; Park, SJ | 1 |
| Guo, C; Guo, X; Huang, S; Li, M; Lv, C; Shang, J; Sun, B; Zhang, W; Zhou, N; Zhu, Y | 1 |
| Castanheira, M; Cotroneo, N; Critchley, I; Hubler, C; Kantro, V; Kimbrough, JH; Mendes, RE | 1 |
| Dong, L; Feng, J; Geng, H; Gu, S; He, C; Hou, G; Ji, T; Kang, W; Lai, J; Li, Y; Li, Z; Pang, D; Wang, Y; Zhao, L; Zhu, X; Zhu, Y | 1 |
| Acampora, A; Albano, R; Buonsenso, D; Ferrari, V; Fiori, B; Pata, D; Sanguinetti, M; Spanu, T; Valentini, P | 1 |
| Arı, O; Durmaz, R; Sancak, B | 1 |
| Chen, L; He, J; Li, X; Pan, H; Quan, J; Wang, Q; Zhang, X | 1 |
| Dong, Y; Ed-Dra, A; Lin, H; Lin, J; Ma, J; Tang, B; Wu, J; Yang, H; Yue, M | 1 |
| Berglund, B; Li, Q; Li, X; Meng, M; Wang, D; Zhao, L; Zou, H | 1 |
| Chen, YH; Cheng, NC; Cheng, Y; Chien, KL; Fang, CT; Hsueh, PR; Tai, HC; Wang, SH | 1 |
| Bai, Y; Chen, R; Hao, Y; Lu, X; Si, Z; Song, Z; Wan, Z; Wang, G; Wang, Q; Wang, Y; Zhang, M | 1 |
| Gao, GL; He, WY; Liu, JH; Lu, YY; Lv, LC; Pu, WX; Zhuang, ZL; Zhuo, C | 1 |
| Ahlstrom, CA; Bonnedahl, J; Ramey, AM; Sandegren, L; Woksepp, H | 1 |
| Abbey, L; Abdelghany, TM; Abdellatif, MH; Abdelmohsen, UR; Abduljaleel Alzawar, NS; Abid, MF; Abu Kasim, AFB; Abu Saad, H; Adolpho, LF; Agostini, F; Agrizii, AP; Ahmed, S; Akce, M; Åkesson, D; Al-Awaadh, AM; Al-Mutar, DMK; Al-Odayni, AB; Al-Rajhi, AMH; Alaaeldin, R; Alam, M; Alam, MM; Alanazi, MA; Alattar, H; Alawlaqi, MM; Aldebis, HK; Algehainy, NA; Almeida, AA; Aloisi, F; Alrahlah, A; Alsenani, F; Alshabib, A; Altemani, FH; Althagafi, A; Amari, A; Andronesi, AG; Antonyuk, M; Arantes, TD; Araújo, R; Arrotti, S; Asakura, T; Asib, N; Atlaskin, AA; Aung, MS; Axiaq, A; Azekawa, S; Bacon, S; Bagalagel, A; Balbinot, GS; Barnet, LS; Baroyi, SAHM; Barreto, F; Barth, Y; Barysheva, AV; Bassa, E; Basu, R; Basu, S; Bates, C; Bautista, LS; Beitl, K; Beloti, MM; Benatti, G; Benavent-Celma, C; Bentaher, A; Bergsland, N; Bernardino, AF; Bernhardt, A; Bhandari, RK; Bhaskaran, K; Bhate, K; Bhattacharjee, A; Bian, X; Bien, EM; Birch, M; Bishara, K; Biswas, JP; Bleha, R; Bocale, R; Bona, S; Boriani, G; Bouyssi, A; Bradley, D; Bravo-Sánchez, MG; Bressan, GC; Brik, A; Brizuela, A; Brockbank, KGM; Buchner, F; Bunc, M; Buscombe, JR; Butler, AJ; Buzaleh, AM; Buzin, MI; Cabrera-Capetillo, CA; Calvo, AM; Camerota, A; Campagna, G; Campisi, M; Cano, K; Cao, HST; Cardellini, S; Carvalho, AP; Carvalho, BCR; Castillo-Baltazar, OS; Cataldo, P; Chai, P; Chakraborty, S; Chalo, DM; Chan, MY; Chander, S; Changbunjong, T; Chappuis, CJF; Chee, RCH; Chen, C; Chen, CJ; Chen, E; Chen, M; Chen, X; Chen, Y; Cheng, HT; Cheng, MC; Cheow, HK; Chi, Y; Chirikova, NK; Chiu, SH; Cho, G; Cho, HR; Cho, S; Cho, SJ; Choe, A; Choe, YH; Chun, BS; Chun, Z; Cinque, A; Ciopec, M; Cladas, Y; Cleary, SP; Clermont, O; Cléroux, M; Cockburn, J; Collares, FM; Colombini-Ishikiriama, BL; Conn, BN; Cortina, JL; Cox, DRA; Crini, G; Croker, R; Cursaru, DL; Curtis, HJ; da Silva, KJG; Dalla Costa, T; Davy, S; de Araújo, BV; de Cassia Ribeiro Gonçalves, R; de Gaetano, F; de Gregorio, C; de Oliveira, MG; De Vera, MAT; de Vos, M; de-la-Fuente, I; Dell'Oca, I; Delles, M; Déméautis, T; Dempster, M; Deng, YH; Denisenko, Y; Descombes, C; Desideri, G; Devarbhavi, H; Devouassoux, G; Di Bella, G; Di Marco, F; Diao, Y; Dias, BB; Dilgin, Y; Dimopoulou, I; Dionísio, TJ; Dobrovic, A; Dokin, ES; Dolby, T; Dong, X; Dong, Y; Dou, SX; Douglas, IJ; Dousset, S; Du, Z; Duan, M; Duan, SB; Duke-Williams, O; Duteanu, N; Dutertre, S; Dutta, S; Dwyer, MG; Ebenbauer, J; Eggo, RM; El-Mordy, FMA; Elbhnsawi, NA; Elrehany, MA; Elshewemi, SS; Elwakil, BH; Emadzadeh, D; Eraso, E; Ermolenko, E; Erten, K; Ettorre, E; Evans, D; Evans, SJ; Faheem, M; Fallanza, M; Faramarzi, M; Faria, FAC; Faro, DC; Fatma, YS; Fazil, S; Feng, Y; Ferguson, J; Fernandes, MH; Fernández-Domínguez, M; Ferrari, LAL; Ferraz, EP; Ferreira, LC; Ferri, C; Fikry, M; Floris, M; Forbes, H; Fotouh, B; Franke, K; Freitas, AC; Freitas, GP; Frieboes, HB; Fu, B; Fu, Y; Fukina, DG; Fukuda, DH; Fukunaga, K; Fulham, GJ; Furlan, L; Furtado Mesa, M; Furtunescu, FL; Gabbieri, D; Ganash, M; Gebers, JC; Gehman, V; Ghaedi, A; Ghazali, NSM; Ghebrekristos, Y; Gil, J; Gilbert, NM; Gimenes, R; Giordano, L; Glehen, O; Godeau, C; Goh, SK; Goldacre, B; Gomes, AM; Gomes, MPO; Gomes, PS; Gomes, RMODS; Gómez-Coma, L; Grenho, L; Gu, Q; Gu, T; Gu, YC; Guiducci, V; Guillemin, JP; Guo, W; Guo, YW; Gur, E; Guridi, A; Guzmán-López, A; Gvozdenko, T; H Elmaidomy, A; Hagar, M; Haider, S; Han, JM; Hanratty, J; Hans, R; Haque, N; Harharah, HN; Harharah, RH; Harper, S; Hasegawa, N; Hassanin, AH; Hastuti, YP; Hatem, AE; He, R; He, Y; Heinemann, C; Heinmaa, I; Heinzl, F; Helfer, VE; Hester, F; Hickman, G; Hill, MA; Hill, WG; Hintze, V; Ho, JSY; Ho, LY; Hoang, T; Holzer, I; Houbraken, J; Hsu, CN; Hu, J; Hu, X; Hu, Y; Hua, T; Huang, Z; Hulme, WJ; Hunter, A; Ianăşi, C; Ibañez, R; Iezzi, R; Iliuță, L; Im, YM; Imran, M; Inglesby, P; Inguimbert, N; Iqbal, A; Izawa, N; Jahaj, E; Jain, S; Jakimovski, D; Jalal, MM; Jaroszuk-Ściseł, J; Jasim, DJ; Jauregizar, N; Javle, MM; Jędryczka, M; Ji, H; Jiang, Y; Jin, J; Johnson, NT; Joshi, S; Jullok, N; Kachapulula, PW; Kaczmarek, J; Kaczmarek-Szczepańska, B; Kadota, K; Kaji, M; Kakeji, Y; Kakizoe, S; Kakudidi, E; Kalitukha, L; Kamata, H; Kang, YJ; Kapinos, AA; Karakaya, S; Kashchenko, NI; Kasyanov, S; Kataky, R; Katati, B; Kato, G; Katsina, AU; Kaya, A; Kaya, H; Kazarina, OV; Ke, Y; Keenan, C; Keilson, JM; Keshavan, A; Keskinidou, C; Khalifa, MA; Khan, R; Khan, S; Kim, D; Kim, K; Kim, MS; Kim, SM; Kim, WH; Kim, Y; Kim, YJ; Kishimura, H; Kitagawa, RR; Klemenkova, ZS; Kloss, F; Kobayashi, N; Kohlhoff, M; Kong, WKF; Konsek, H; Kornaros, M; Kotanidou, A; Kovacs, S; Kraska, J; Kruppke, B; Kumagai, Y; Kumar, S; Kumari, R; Kuruva, V; Kuster, RM; Kusumoto, T; Kutyła, M; Kwon, JH; Kwon, SH; Kwong, KY; Kyser, AJ; Lackner, M; Lass-Flörl, C; Lauri, C; Lavandera, JV; Lee, BH; Lee, ECY; Lee, HJ; Lee, J; Lee, PS; Lee, S; Lee, SE; Lee, SY; Lefort, F; Leite, JPV; Leo, G; Leonard, R; Leow, AST; Lepori, N; Leyden, K; Leys, L; Ležaić, L; Li, D; Li, H; Li, J; Li, S; Li, TYW; Li, X; Li, XH; Li, Y; Li, Z; Li, ZH; Liao, S; Liaqat, K; Lim, H; Lin, BS; Lin, MY; Lin, NH; Lin, X; Lin, Y; Liu, C; Liu, H; Liu, HK; Liu, HX; Liu, P; Liu, R; Liu, T; Liu, X; Liu, Y; Lock, GA; Lokaj, G; Lopes, HB; Losi, V; Lotsios, NS; Low, KE; Lu, Z; Luhana, S; Luo, X; Luo, XQ; Lutz, MB; Lysova, AA; Lyssenko, KA; Macit, M; MacIver, B; MacKenna, B; Magalhães, GAP; Magnavacchi, P; Mahadevan, J; Mahboubi, A; Maher, SA; Mahipal, A; Mahmoud, MY; Maithel, SK; Makhtar, MMZ; Makurat-Kasprolewicz, B; Malysheva, YB; Mansourizadeh, A; Marek, EJ; Maresca-Fichter, H; Martin, JT; Maslov, AA; Mastora, Z; Mastroiacovo, D; Mastropetros, SG; Matei, D; Mathur, R; Matos, AO; Matsuda, Y; Maurya, SK; Mayor, Á; Mayrhofer, D; Mazzuco, AC; McCaffrey, J; McClure, T; McDonald, HI; Mchunu, NP; McLaggan, D; Mehrkar, A; Meilik, B; Melito, VA; Mellem, J; Mengozzi, A; Menotti, J; Mesquita, V; Miao, Z; Mihai, S; Miller, S; Minassian, C; Mirabile, A; Mitra, S; Mladin, G; Mo, Z; Moawad, H; Mohamed, EM; Mohammed, TJ; Mohanlall, V; Mohyeldin, RH; Moldovan, H; Monneret, G; Monopoli, DE; Monte, IP; Monteiro, JRB; Morgante, V; Mori, M; Morin-Crini, N; Morita, A; Morton, CE; Mrak, M; Muhammed, AP; Mulick, A; Muralidharan, V; Murthy, P; Muselli, M; Mustafa, S; Mysore Visweswariah, A; Nagao, G; Naicker, S; Nakagawara, K; Namgoong, B; Namkoong, H; Namukobe, J; Nasir, AA; Nasreen, SA; Natarajan, P; Nchiozem-Ngnitedem, VA; Necozione, S; Negrea, A; Negrea, P; Ngubane, S; Nguyen, TT; Nicke, A; Nightingale, E; Nistor, CL; Nitsch, D; Njapau, H; Noman, M; Novgorodtseva, T; Nowak, A; O'Connor, SR; Ofoe, R; Oh, K; Oh, TH; Oki, E; Olama, ZA; Olennikov, DN; Oliveira, GM; Omar, D; Ong, SJ; Orfanos, SE; Origa-Oryem, H; Orita, H; Ortiz, I; Ota, M; Ott, J; Otvagina, KV; Pacheco, N; Pacheco, RR; Padmanabhan, D; Pagan, JD; Pagnotta, PA; Palangi, V; Palanisamy, G; Palanisamy, K; Palanisamy, S; Pan, SG; Panaitescu, E; Pang, X; Panoutsakopoulos, V; Parera, VE; Park, JI; Park, JS; Park, SW; Park, Y; Park, YS; Parkash, O; Parry, J; Parry, JP; Paul, SK; Pavšič, N; Pałubicka, A; Persat, F; Petriz-Prieto, MA; Petukhov, AN; Pham, T; Pillay, S; Poh, KK; Ponomarev, II; Pontons-Melo, JC; Posa, A; Powell, E; Priya, AK; Punekar, R; Puppin Rontani, RM; Purushottam, M; Pusphanathan, K; Qi, JY; Qin, J; Qin, Z; Qiu, B; Qiu, X; Quattrini, G; Quindós, G; Qureshi, F; Rabbany, MA; Rac-Albu, M; Rac-Albu, ME; Rădulescu, BC; Rafatullah, M; Rajab, TK; Rajna, S; Ramanathan, M; Rao, D; Raviglione, D; Razorenov, DY; Redd, MJ; Rehman, W; Reig, M; Rentsch, CT; Ribeiro, LMS; Robles, D; Rocchi, S; Rocha, FG; Rodrigues, C; Rodrigues, LA; Rodrigues, RP; Roh, GH; Ronowska, A; Root, A; Rosa, AL; Rossi, R; Roy, S; Roy, VC; Rupji, M; Saber, EA; Sadarat, F; Saed, Y; Saeed, WS; Saeki, H; Saha, B; Saiwichai, T; Sakowicz-Burkiewicz, M; Sampedro, T; Sands, K; Santos, CF; Sari, M; Sathi, FA; Sauro, S; Sazanova, TS; Scafa-Udriște, A; Schoustra, SE; Schultze, A; Seo, DJ; Sevillano, E; Sezmis, G; Sgura, FA; Shah, NNAK; Shani, N; Shankarappa, B; Sharkey, LM; Sharma, VK; Sharp, C; Shehata, N; Shelton, N; Shieh, PB; Shimokawa, M; Shin, J; Shin, SH; Shin, YN; Shin, YR; Shipilova, A; Shoparwe, NF; Shukor, H; Sia, CH; Siddiqui, MH; Siddiqui, MR; Siena, V; Signore, A; Silwane, B; Siqueira-Sandrin, VS; Siregar, A; Sirignano, P; Sit, NW; Skidmore, S; Skupov, KM; Smeeth, L; Smoczer, C; Smolyanskiy, E; Sohn, H; Solodeev, I; Solovyev, A; Şomoghi, R; Song, F; Song, H; Song, Z; Souf, YM; Sousa, SC; Souza, MT; Steinbach-Rankins, JM; Stockton, J; Stout, JR; Su, K; Su, MZ; Suarez-Lopez, YA; Sukkurd, R; Sultanov, R; Sun, Y; Sun, Z; Supernak, M; Supriyono, E; Suroshe, SS; Suvorov, SS; Svera M Ianăşi, P; Switchenko, JM; Syarif, NY; Synytsya, A; Taherzadeh, MJ; Tain, YL; Tamburino, C; Tammam, OY; Tan, BYQ; Tan, H; Tan, S; Tanaka, H; Tang, R; Tang, X; Tang, Z; Taurino, M; Tazare, J; Teresi, L; Testro, A; Thanasoponkul, W; Thangarasu, S; Thavaselvam, D; Theodoro, RC; Theron, G; Thomas, RH; Thomson, JJ; Tian, X; Tian, Y; Tomaszewski, CA; Tomlinson, LA; Torres, CMME; Tóth, M; Trecourt, A; Trevisani, F; Trimarchi, G; Tristán, C; Truong, VK; Tsigkou, K; Tsutsumi, S; Ubukata, Y; Uehara, H; Uwamino, Y; Vahedi-Shahandashti, R; Valberg, SJ; Valderrama, C; Valdovinos-García, EM; Valsecchi, D; van Diepeningen, AD; van West, P; Vargas-Osuna, E; Vassall, M; Vassilaki, N; Vassiliou, AG; Vecino, X; Velez-Irizarry, D; Venkatesh, YN; Vignali, L; Virdis, A; Viswanath, B; Voisin, AS; Volkova, YA; Vorotyntsev, AV; Vorotyntsev, IV; Vtyurina, ES; Vu, DH; Waldridge, B; Walker, AJ; Wallon, M; Wang, B; Wang, G; Wang, H; Wang, J; Wang, LJ; Wang, S; Wang, T; Wang, X; Wang, Z; Warren, RM; Warren-Gash, C; Wei, SH; Weinstock-Guttman, B; Wekwejt, M; Wessjohann, LA; Wiesmann, HP; Williams, ZJ; Williamson, EJ; Wilson, M; Wing, K; Wong, AY; Wong, BKL; Woodward, S; Wozniak, KL; Wu, C; Wu, K; Wu, S; Wu, Y; Xiang, D; Xie, H; Xiong, X; Xu, C; Xu, H; Xu, J; Xu, WH; Xu, Y; Xun, T; Yamaguchi, S; Yan, P; Yan, W; Yan, Z; Yang, B; Yang, F; Yang, L; Yao, XB; Yasui, H; Yenesew, A; Yeo, LLL; Yeo, TC; Yi, S; Yin, F; Yip, JWL; Yoon, SH; Yoon, SJ; Yoshida, M; Yoshizumi, T; Young, LA; Yu, C; Yu, DD; Yu, F; Yu, H; Yu, JD; Yu, NJ; Yu, X; Yuan, Y; Yurenko, A; Yusof, YA; Zahedipoor, A; Zahran, EM; Zainuddin, NI; Zanatta, AC; Zanotto, ED; Zanozin, ID; Zavascki, AP; Zenke, M; Zhang, F; Zhang, G; Zhang, H; Zhang, J; Zhang, L; Zhang, MX; Zhang, NY; Zhang, Q; Zhang, W; Zhang, X; Zhang, XM; Zhao, F; Zhao, Q; Zhao, R; Zhao, Y; Zheng, J; Zheng, S; Zhou, L; Zhou, X; Zhu, H; Zivadinov, R; Žižek, D; Zuccoli, JR; Zwaan, BJ | 1 |
| Birinci, A; Ertokatlı, M; Güney, DB; Hacıeminoğlu Ülker, K; Karacan Temür, G; Tanrıverdi Çaycı, Y | 1 |
| Abdul Jabar, K; Abu Bakar, S; Ahmed Khan, A; Chong, CW; Harun, A; Ismail, Z; Jasni, AS; Karunakaran, R; Kong, ZX; Lau, MY; Lee, YQ; Leong, KC; Lim, VKE; Mak, ST; Masri, SN; Md Noor, SS; Mohd Taib, N; Ngoi, ST; Ponnampalavanar, S; Ramli, R; Salleh, SA; Tan, SC; Tee, LH; Teh, CSJ; Tengku Jamaluddin, TZM; Woon, JJ; Yap, PSX | 1 |
| Alsharapy, SA; Bertrand, X; Brasme, L; Cholley, P; De Champs, C; Gharout-Sait, A; Guillard, T; Moghram, GS; Muggeo, A; Touati, A | 1 |
| Antonelli, A; Camarlinghi, G; Coppi, M; Giani, T; Mattei, R; Nardone, M; Parisio, EM; Riccobono, E; Rossolini, GM | 1 |
| Bhattacharjee, A; Bhowmik, D; Bora, D; Chakravarty, A; Chanda, DD; Chetri, S; Pandey, P; Paul, D | 1 |
| Fihman, V; Lafaurie, M; Lepeule, R; Lescure, X; Lesprit, P; Nguyen, Y; Oubaya, N; Senard, O; Therby, A | 1 |
| Choi, Q; Koo, SH; Kwon, GC; Park, Y | 1 |
| Choi, J; Dantas, G; Das, S; Gandra, S; Green, SJ; Harazin, M; McElvania, E; Singh, KS; Thomson, RB | 1 |
| Guo, Y; Lu, N; Lv, Q; Qiu, J; Sun, X; Wang, J; Zhang, P; Zhou, Y | 1 |
| Ceric, O; Cole, SD; Peak, L; Rankin, SC; Reimschuessel, R; Tyson, GH | 1 |
| Anandan, S; Daniel, JLK; Devanga Ragupathi, NK; Iyadurai, R; Muthuirulandi Sethuvel, DP; Mutreja, A; Neeravi, AR; Sathyendra, S; Vasudevan, K; Veeraraghavan, B | 1 |
| Bhattacharjee, A; Bhowmik, D; Chakravarty, A; Chanda, DD; Chetri, S; Das, BJ | 1 |
| Almaeen, AH; Bandy, A | 1 |
| Han, S; Hong, CK; Kim, HS; Kim, J; Kim, JS; Lee, SM; Oh, YH; Park, J; Park, SH; Yu, JK | 1 |
| Gao, B; Sheng, Q; Tu, M; Wang, M; Wang, P | 1 |
| Board, MM; Crespo, R; Faux, C; Guard, J; Paul, NC; Shah, DH | 1 |
| Berk, H; Kizilates, F; Otlu, B; Oztoprak, N; Yakupogullari, Y | 1 |
| Alba, P; Battisti, A; Buccella, C; Carfora, V; Dell'Aira, E; Di Matteo, P; Diaconu, EL; Franco, A; Onorati, R; Sorbara, L; Stravino, F | 1 |
| Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
| Deemer, K; Fronczek, C; Grey, J; Marr, K | 1 |
| Chakraborty, T; Falgenhauer, J; Falgenhauer, L; Hauri, AM; Heinmüller, P; Imirzalioglu, C; Nordmann, P; Yao, Y | 1 |
| Al-Azri, S; Al-Farsi, HM; Al-Jardani, A; Al-Muharrmi, Z; Camporeale, A; Giske, CG; Ininbergs, K | 1 |
| Hao, Q; Ho, PL; Kao, RY; Li, H; Sun, H; Wang, H; Wang, M; Wang, R; Wong, YT; Yan, A; Zhang, Q | 1 |
| Boutin, S; Heeg, K; Miethke, T; Nurjadi, D; Welker, S | 1 |
| Cisera, K; Hughes, C; Rogers, B; Taylor, L; Xie, O | 1 |
| Hirabayashi, A; Kajihara, T; Shibayama, K; Sugai, M; Yahara, K | 1 |
| Katip, W; Oberdorfer, P; Uitrakul, S; Yoodee, J | 1 |
| de Haan, A; Hendrickx, APA; Landman, F; Schouls, LM; van Santen-Verheuvel, MG; Witteveen, S | 1 |
| Agga, GE; Martin, RS; Silva, PJ | 1 |
| Angulmaduwa, S; De Silva, K; Ekanayake, A; Ip, M; Kalupahana, R; Kuthubdeen, S; Liyanapathirana, V; Munasinghe, T; Subhasinghe, S; Vidanapathirana, G | 1 |
| Dao, TD; Hasebe, F; Hirabayashi, A; Kasuga, I; Shibayama, K; Suzuki, M; Takemura, T; Thanh, NH; Tran, HH; Trang, LT | 1 |
| Beloeil, PA; Bortolaia, V; Guerra, B; Hansen, IM; Hendriksen, RS; Hoffmann, M; Kjeldgaard, JS; Leekitcharoenphon, P; Milita, NM; Mordhorst, H; Nicorescu, I; Romascu, L; Ronco, T; Svendsen, CA; Vaduva, AM | 1 |
| Amudhan, M; Mythreyee, M; Sekar, R; Srivani, S | 1 |
| Cherng, BPZ; Choon, RFK; De, PP; Deepak, RN; Fisher, D; Hsu, LY; Khong, WX; Koh, TH; Krishnan, PU; Kurup, A; Lam, CW; Lee, JJ; Lin, RTP; Ling, ML; Marimuthu, K; Ng, OT; Ong, RT; Ooi, ST; Pada, SK; Peng, BAS; Sim, NTW; Smitasin, N; Tan, EL; Tan, TY; Teo, J; Teo, YY; Thoon, KC; Van La, M; Venkatachalam, I; Young, B | 1 |
| Abe, Y; Fukuchi, K; Hashimoto, K; Hibino, S; Inan-Erdogan, I; Itabashi, K; Matsuhashi, K; Ogawa, Y; Sakurai, S; Ugajin, K; Wakabayashi, H; Watanabe, Y | 1 |
| Choi, JK; Joo, EJ; Ko, JH; Lee, NR; Moon, SY; Park, DA; Peck, KR | 1 |
| Bauerfeind, R; Ewers, C; Prenger-Berninghoff, E; Pulss, S; Semmler, T | 1 |
| Ding, Y; Feng, Y; Hassan, B; Li, J; Li, XP; Lin, J; Sun, J; Wang, Q | 1 |
| Cui, S; Ding, H; Luo, H; Luo, R; Luo, Y; Ren, X; Ye, L; Zhang, Y | 1 |
| Arlet, G; Ben Hassine, I; Chachaty, E; Decré, D; Forget, S; Jardak, T; Woerther, PL | 1 |
| Fujimoto, H; Kakeya, H; Kaneko, Y; Namikawa, H; Oinuma, KI; Shuto, T; Takemoto, Y; Tochino, Y; Yamada, K | 1 |
| Akeda, Y; Aye, MM; Hagiya, H; Hamada, S; Motooka, D; Nakamura, S; Nishi, I; Okada, K; Sakamoto, N; Sugawara, Y; Takeuchi, D; Tomono, K; Yamamoto, N; Yoshida, H; Zin, KN | 1 |
| Castanheira, M; Davis, AP; Deshpande, LM; Le, J; Turner, N | 1 |
| Kim, JH; Kim, MJ; Kim, SB; Sohn, JW; Suh, JW; Yang, KS; Yoon, YK | 1 |
| Abdala, E; Cury, AP; da Silva Duarte, AJ; da Silva, AM; Girardello, R; Martins, LF; Morais, C; Rossi, F; Setubal, JC | 1 |
| Batra, J; Doda, A; Gandhoke, I; Grover, SS; Gupta, N; Hans, C; Khare, S | 1 |
| Cao, H; Chow, KH; Ho, PL; Lai, EL; Law, PY; Liu, MC; Wang, Y | 1 |
| Khedkar, S; Khedkar, U; Lind, F; Nerkar, SS; Odsbu, I; Orsini, N; Stålsby Lundborg, C; Tamhankar, AJ | 1 |
| Krishnaswamy, N; Murugan, MS; Nirupama, KR; O R, VK; Pruthvishree, BS; Singh, BR; Sinha, DK | 1 |
| Asadi Karam, MR; Bouzari, S; Habibi, M; Shahbazi, S; Talebi, A | 1 |
| Gupta, S; Mukhopadhyay, C; Pathak, A; Prasad, KN; Rahman, M; Rai, RP; Singh, A; Singh, S | 1 |
| Du, X; Fu, Y; Hu, Q; Huang, D; Li, X; Shen, M; Wang, D; Yu, Y; Zhou, Y | 1 |
| Adak, S; Bulagonda, EP; Khamari, B; Mahalingam, N; Manivannan, B; Siddaramappa, S | 1 |
| Borghi, M; Bueno Freitas, L; Cruz Spano, L; Pinto Schuenck, R; Santos Almeida, M; Soares Jardim Lacerda Batista, J; Tonini, MA | 1 |
| Kato, A; Kirikae, T; Miyairi, I; Sugahara, Y; Tada, T; Uchida, H | 1 |
| Eklund, M; Grönthal, T; Jalava, J; Nykäsenoja, S; Österblad, M; Pekkanen, K; Rantala, M | 1 |
| Feng, Y; Lei, S; Liu, W; Mao, J; Sun, J; Wang, W | 1 |
| Aziz, FN | 1 |
| Alousi, S; Arabaghian, H; Araj, GF; Dagher, C; Salloum, T; Tokajian, S | 1 |
| Hayden, MK; Won, SY | 1 |
| Chen, Z; Kang, M; Li, M; Liu, M; Song, Q; Wu, L; Xie, Y; Zhao, D | 1 |
| Jia, H; Li, B; Liu, J; Liu, K; Ma, Z; Qiu, Y; Shao, D; Tong, H; Wei, J; Yao, X | 1 |
| Cheng, J; Feng, X; Liu, HM; Qin, S; Wang, P | 1 |
| Gao, Y; Guo, R; Lu, L; Shen, H; Yu, Y; Zhu, C | 1 |
| Bedenić, B; Drenjančević, D; Kopić, J; Presečki-Stanko, A; Talapko, J; Tomić Paradžik, M; Zarfel, G | 1 |
| An, JH; Gong, Y; Han, S; Hong, CK; Jin, YH; Jung, K; Jung, SW; Kim, DW; Kim, HS; Kim, IY; Kim, J; Kim, JS; Kim, S; Lee, JH; Park, JH; Park, SH | 1 |
| Jin, X; Jin, Y; Wang, K; Wang, Y; Yu, J; Zhang, Q | 1 |
| Cao, L; Chang, J; Ji, X; Luo, Q; Lyu, W; Qian, M; Tang, B; Xia, X; Xu, H; Yang, H; Zhang, Q | 1 |
| Cusack, TP; Dance, DAB; Duangmala, K; Hopkins, KL; Phan, HTT; Phimolsarnnousith, V; Phoumin, P; Shetty, N; Stoesser, N; Turton, J; Woodford, N | 1 |
| Huang, J; Huang, X; Huang, Y; Liu, E; Liu, JH; Lu, J; Lv, L; Song, Q; Wan, M; Xun, H; Zhang, Q; Zhang, Z; Zhuang, Z; Zhuo, C | 1 |
| Bruderer, V; Greiner, M; Imkamp, F; Keller, PM; Mancini, S | 1 |
| Goodman, JL; Hartley, DM; Koch, M; Malchione, MD; Torres, LM | 1 |
| Fang, C; Hou, Z; Hu, Y; Li, M; Lu, L; Luo, X; Ma, B; Wang, M; Xue, X; Zhou, Y | 1 |
| Bertrand, X; Chirouze, C; Cholley, P; Fournier, D; Leroy, J; Plésiat, P; Talon, D | 1 |
| Hernández, E; Picazo, JJ; Rodríguez-Avial, C; Rodríguez-Avial, I | 1 |
| Li, W; Liu, G; Liu, Z; Lu, F; Ma, Y; Pan, J; Qi, J; Sun, S; Wang, J; Yu, Y; Zhang, T; Zhao, B | 1 |
| Lastovetska, O; Low, DE; Macmullin, G; Melano, RG; Patel, SN; Stacey-Works, T; Tijet, N; Vermeiren, C; Wenzel, P | 1 |
| Bethe, A; Ewers, C; Guenther, S; Hassdenteufel, E; Pfeifer, Y; Prenger-Berninghoff, E; Scheufen, S; Stamm, I; Stolle, I | 1 |
| Chuang, YC; Fung, CP; Lin, JC; Lu, PL; Ma, L; Siu, LK; Wang, JT; Wu, TL | 1 |
| Anh, ND; Chan, WM; Garcia, J; Harijanto, E; Lee, C; Loo, CM; Mustafa, M; Van Kinh, N | 1 |
| Al Johani, SM; Al Salman, J; Al-Abri, S; Al-Jardani, A; Alfaresi, M; AlJindan, RY; Balkhy, HH; Dashti, AA; Ibrahim, E; Kutbi, AH; Paterson, DL; Sartor, AL; Schlebusch, S; Sidjabat, HE; Walsh, TR; Zowawi, HM | 1 |
| Farrell, R; Kopacz, J; Mariano, N; Piracha, N; Prasad, N; Segal-Maurer, S; Shakil, J; Tarasuk, A; Urban, C; Wang, G | 1 |
| Kirikae, T; Miyoshi-Akiyama, T; Shimada, K; Tada, T | 1 |
| Doi, Y; Qureshi, ZA | 1 |
| Bille, E; Emirian, A; Groh, M; Guet-Revillet, H; Join-Lambert, O; Jullien, V; Nebbad-Lechani, B; Weiss, E; Zahar, JR | 1 |
| Ahn, JY; Ann, HW; Choi, H; Choi, JY; Han, SH; Jeon, Y; Jeong, SJ; Kim, JH; Kim, JK; Kim, JM; Kim, MH; Kim, SB; Ku, NS; Lee, K; Song, JE; Song, YG; Yong, D | 1 |
| Iredell, JR; Partridge, SR; Tagg, KA | 1 |
| Acar, A; Aktas, Z; Budak, S; Erdem, H; Gorenek, L; Oncul, O; Ozyurt, M; Turhan, V | 1 |
| Chandran, SP; Diwan, V; Joseph, BV; Lundborg, CS; Macaden, R; Mundayoor, S; Rosales-Klintz, S; Tamhankar, AJ | 1 |
| Chang, YY; Chuang, YC; Fung, CP; Huang, LJ; Lin, JC; Lin, YT; Lu, PL; Siu, LK; Wang, JT; Wang, LS; Wu, TL | 1 |
| Crandon, JL; MacVane, SH; Nichols, WW; Nicolau, DP | 1 |
| Hampton, T | 1 |
| Li, J; Mukhopadhyay, A; Tambyah, PA; Vasudevan, A; Yuen, EG | 1 |
| Boyd, D; Bryce, E; Embree, J; Fuller, J; Gravel, D; Katz, K; Kibsey, P; Kuhn, M; Langley, J; Mataseje, L; Mitchell, R; Mulvey, M; Roscoe, D; Simor, A; Taylor, G; Thomas, E; Turgeon, N | 1 |
| Garrec, H; Jarlier, V; Lafeuille, E; Laouira, S; Leconte, J; Robert, J; Sougakoff, W; Soulier-Escrihuela, O; Tourret, J | 1 |
| Dua, KS; Edmiston, CE; Khan, AH; Massey, BT; Oh, YS; Saeian, K; Smith, ZL | 1 |
| Huang, SF; Pu, SL; Sun, JD; Yang, SS; Zhang, CM; Zhang, LP | 1 |
| Hong, MT; Seifert, CF | 1 |
| Baliga, C; D'Angeli, M; Duchin, J; Eckmann, K; Gluck, M; Kang, MG; Kay, M; Ross, AS; Swoveland, J; Verma, P; Weissman, SJ; Wendorf, KA | 1 |
| Rutala, WA; Weber, DJ | 1 |
| Hiraki, K; Murakami, N; Sugawara, T; Uetake, N | 1 |
| Eslami, G; Langaee, T; Rafati, M; Rafiei, A; Rezai, MS; Salehifar, E; Shafahi, K | 1 |
| Adámková, V; Balejova, M; Bergerová, T; Chmelařová, E; Dvořáková, L; Hrabák, J; Jakubů, V; Ježek, P; Kabelíková, P; Kolář, M; Papagiannitsis, C; Paterová, P; Študentová, V; Tejkalová, R; Žemličková, H | 1 |
| Carbonnelle, E; Compain, F; Geri, G; Kernéis, S; Lavollay, M; Mainardi, JL; Rostane, H; Valade, S | 1 |
| Batbaatar, G; Bolormaa, E; Huang, AH; Huang, YT; Kao, CY; Khosbayar, T; Udval, U; Urangoo, Z; Wu, HM; Wu, JJ; Yan, JJ | 1 |
| Delory, T; Emirian, A; Groh, M; Lecuyer, H; Lesprit, P; Pilmis, B; Weiss, E; Zahar, JR | 1 |
| Chen, FJ; Chien, CC; Lee, CH; Li, CC; Liu, JW; Su, LH; Tang, YF | 1 |
| Bethel, CR; Bonomo, RA; Doi, Y; Endimiani, A; Kasraian, S; Pires, J; Sendi, P; Taracila, M; Tinguely, R | 1 |
| Hsueh, PR; Ko, WC; Lee, CC; Lee, NY; Li, CW; Li, MC; Lo, CL | 1 |
| Han, SB; Jeong, DC; Kang, JH; Lee, SC; Lee, SY | 1 |
| Kamath, S; M Shenoy, S; Sinha, R | 1 |
| Cui, T; Su, M; Wang, J; Yan, H; Yang, H; Yang, Z; Yao, Q; Zhan, Y; Zhao, P | 1 |
| Dong, F; Guo, L; Li, S; Liu, G; Liu, L | 1 |
| Aberkane, S; Bouzinbi, N; Compain, F; Decré, D; Godreuil, S; Hide, M; Jean-Pierre, H; Ouédraogo, AS; Ouédraogo-Traoré, R; Sangaré, L; Sanou, M; Solassol, J; Vendrell, J | 1 |
| Cipolla, A; D'Abramo, A; De Angelis, M; Favaro, M; Ferretti, G; Gizzi, F; Iannetta, M; Mascellino, MT; Mastroianni, CM; Oliva, A; Russo, G; Vullo, V | 1 |
| Ahlstedt, E; Caceres, M; Hasan, B; Hernandez, J; Järhult, JD; Laurell, K; Rakib, MM | 1 |
| Angkititrakul, S; Chaimanee, P; Chanawong, A; Charoensri, N; Chetchotisakd, P; Lulitanond, A; Lunha, K; Saenjamla, P; Wilailuckana, C; Wonglakorn, L | 1 |
| Boudehouche, W; Haenni, M; Madec, JY; Saras, E; Touati, A; Yaici, L | 1 |
| Chen, YB; Huang, JA; Zhang, M | 1 |
| Kumar, M; Saha, S; Subudhi, E | 1 |
| Chavda, KD; Chen, L; Dever, LL; Kreiswirth, BN; Mathema, B; Mediavilla, JR; Patrawalla, A; Vinnard, C | 1 |
| Chan, EW; Chen, K; Chen, S; Li, R; Lin, D; Xie, M | 1 |
| Cheng, GY; Guan, R; Jiang, W; Kong, LH; Lei, CW; Liu, BH; Ma, SZ; Men, S; Wang, HN; Wang, YX; Yuan, QW; Zhou, WC | 1 |
| Boisson, MN; Boulouis, HJ; Haenni, M; Madec, JY; Médaille, C; Melo, LC; Saras, E | 1 |
| Boyanova, L; Kaneva, R; Markovska, R; Mitev, V; Mitov, I; Pencheva, D; Stankova, P; Stoeva, T | 1 |
| Dobashi, H; Imataki, O; Kadowaki, N; Kuwahara, T; Matsuka, H; Mori, H; Nakayama-Imaohji, H; Ohue, Y; Uchida, S; Uemura, M | 1 |
| Duan, J; Fu, C; Gong, R; Huang, X; Li, C; Liu, S; Liu, Y; Meng, X; Wu, A; Xiong, X; Zhang, Y; Zhou, P | 1 |
| Alonso-Isa, M; Benítez-Sala, R; García-Rojo, E; Gil-Moradillo, J; González-Padilla, DA; Justo-Quintas, J; Lara-Isla, A; Medina-Polo, J; Passas-Martínez, JB; Sopeña-Sutil, R; Tejido-Sánchez, Á | 1 |
| Bhattacharjee, A; Chakravarty, A; Choudhury, NA; Dhar, D; Ingti, B; Maurya, AP; Paul, D | 1 |
| Bhattacharjee, A; Garg, A; Paul, D | 1 |
| Al-Abri, SS; Al-Jardani, A; Aldeesi, Z; Carattoli, A; Darwish, D; Ghazawi, A; Hashmey, R; Jamal, W; Pál, T; Rotimi, V; Sonnevend, Á; Villa, L | 1 |
| Ajao, AO; Albrecht, JS; Furuno, JP; Harris, AD; Johnson, JK; Pineles, LL; Robinson, GL; Thom, KA; Zhao, L | 1 |
| Fernando, MM; Gunathilake, MP; Luke, WA; Miththinda, JK; Premaratna, R; Sebastiampillai, BS; Silva, FH; Wickramasinghe, RD | 1 |
| Ahmed, AM; Hara, T; Ikeda, M; Kayama, S; Khalifa, HO; Kuroo, Y; Shimamoto, T; Soliman, AM; Sugai, M | 1 |
| Chen, CC; Chuang, YC; Lai, CC; Tang, HJ | 1 |
| Apisarnthanarak, A; Kiratisin, P; Mundy, LM | 1 |
| Choi, SH; Chung, JW; Jeon, MH; Jeong, JY; Kim, YS; Kwak, YG; Lee, SO; Woo, JH | 1 |
| Dropa, M; Elmor de Araújo, MR; Grinbaum, RS; Lincopan, N; Mamizuka, EM; Matté, MH; Neves, P; Pavez, M | 1 |
| Lortholary, O; Martin, C; Nordmann, P; Plesiat, P; Potel, G; Zahar, JR | 1 |
| Protonotariou, E; Sofianou, D; Vitti, D | 1 |
| Abid, J; Adams-Haduch, JM; Doi, Y; Dossenback, DA; Halstead, DC; Paterson, DL; Sellen, TJ | 1 |
| Baudry, PJ; Cox, L; Hoban, DJ; Karlowsky, JA; Tailor, F; Zhanel, GG | 1 |
| Doherty, JA; Khan, J; Kollef, MH; Micek, ST; Pervez, M; Reichley, RM; Welch, EC | 1 |
| Kiratisin, P; Leelaporn, A; Leelarasmee, A; Netikul, T | 1 |
| Carmeli, Y; Chmelnitsky, I; Goren, MG; Navon-Venezia, S | 1 |
| Mariano, N; Rahal, JJ; Urban, C | 1 |
| Badal, RE; Baquero, F; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ | 1 |
| Ko, WC; Lee, CC; Wu, JJ; Yan, JJ; Yang, FC | 1 |
| Fluit, AC; Leverstein-Van Hall, MA; Stuart, JC; Tersmette, T; Versteeg, D; Voets, GM | 1 |
| Koemtzidou, E; Lebessi, E; Papadimitriou, M; Ranellou, K; Tsakris, A; Voulgari, E | 1 |
| Arda, B; Pullukcu, H; Senol, S; Sipahi, H; Sipahi, OR; Tasbakan, M; Ulusoy, S; Yamazhan, T | 1 |
| Du, X; Jiang, X; Li, G; Wang, Y; Wei, Q; Zhao, Y | 1 |
| Chryssouli, Z; Galani, I; Giamarellos-Bourboulis, E; Giamarellou, H; Konstantinidou, E; Pefanis, A; Souli, M; Tsaganos, T; Tzepi, I | 1 |
| Ahmed-Bentley, J; Peirano, G; Pitout, JD; Woodford, N | 1 |
| Ersoy, Y; Görgeç, S; Kuzucu, C; Yetkin, F | 1 |
| Goff, DA; Parbhoo, RK; Schafer, JJ; Winters, HA | 1 |
| Hsueh, PR; Huang, WH; Ko, WC; Lee, NY; Tsui, KC | 1 |
| Chang, HJ; Chia, JH; Hsu, PC; Kuo, AJ; Lee, MH; Wu, TL; Yang, CC | 1 |
| Alış, EE; Cengiz, M; Ekici, S; Turan, G | 1 |
| Sekar, U; Shanthi, M | 1 |
| Akpaka, PE; Legall, B; Padman, J | 1 |
| Courcol, R; Cuzon, G; Gaillot, O; Naas, T; Nordmann, P | 1 |
| Baba, S; Fujita, T; Iwamura, M; Kimura, M; Kurosaka, S; Matsumoto, K; Minamida, S; Satoh, T; Tabata, K; Tsumura, H | 1 |
| Bhusal, Y; Mihu, CN; Rolston, KV; Tarrand, JJ | 1 |
| Hornsey, M; Phee, L; Wareham, DW | 1 |
| Chen, G; Hu, ZQ; Ito, R; Kimura, S; Zhao, WH | 1 |
| López, M; Martín, C; Rojo-Bezares, B; Sáenz, Y; Torres, C | 1 |
| Acosta, F; Cottagnoud, M; Cottagnoud, P; Egerman, U; Laeuffer, JM; Stucki, A | 1 |
| Chau, F; Fantin, B; Le, P; Lefort, A; Lepeule, R; Massias, L; Nucci, A; Ruppé, E | 1 |
| Dalekos, GN; Malli, E; Mavroidi, A; Miriagou, V; Petinaki, E; Stefos, A; Tzouvelekis, LS | 1 |
| Bauernfeind, A; Bojkova, K; Gergova, R; Ivanova, D; Keuleyan, E; Markova, B; Markovska, R; Mitov, I; Schneider, I; Sredkova, M; Stoeva, T | 1 |
| Balan, G; Ho, WS; Koh, XP; Kong, BH; Lim, KT; Puthucheary, S; Tan, LK; Thong, KL; Yeo, CC | 1 |
| Chen, H; Chen, M; Liu, Y; Wang, H; Zhang, F; Zhao, C | 1 |
| Ikeda, Y; Koseki, T; Mamiya, T; Mouri, A; Nabeshima, T; Narusawa, S; Nishiyama, H | 1 |
| Hsueh, PR; Lee, YJ; Lin, YC; Liu, HY; Wu, HH | 1 |
| Araj, GF; Baroud, M; El-Herte, RI; Kanafani, ZA; Kanj, SS; Matar, GM | 1 |
| Chan, KS; Choudhury, S; Koh, TH | 1 |
| Brun-Buisson, C; Derde, LP; Legrand, P; Lesprit, P; Razazi, K; Verachten, M | 1 |
| Benenson, S; Block, C; Hidalgo-Grass, C; Moses, AE; Strahilevitz, J; Temper, V; Warburg, G | 1 |
| Chan, JF; Cheng, VC; Ho, PL; Lo, WU; To, KK; Tse, H | 1 |
| Anh, DD; Duong, TN; Hien, NT; Hoang, TH; Izumiya, H; Minh, NB; Ohnishi, M; Phuong, TT; Shibayama, K; Son, TH; Wertheim, H | 1 |
| Ahmed, S; Cherabuddi, K; Chundi, V; Hayden, MK; Lin, MY; Lolans, K; McNally, M; Norris, A; Odeh, R; Prabaker, K; Weinstein, RA | 1 |
| Bachmann, A; Bonkat, G; Braissant, O; Frei, R; Gasser, TC; Müller, G; Rieken, M; Tschudin-Suter, S; Widmer, AF; Wyler, S | 1 |
| Chlebicki, MP; Oh, HM | 1 |
| Chang, LY; Hsueh, PR; Huang, LM; Lee, CY; Lee, PI; Lu, CY; Shao, PL; Wang, CY; Wu, TZ; Yang, CY | 1 |
| Cakir, B; Hascelik, G; Metan, G; Uzun, O; Zarakolu, P | 1 |
| Mikamo, H; Totsuka, K | 1 |
| Chiu, S; Chou, YH; Huang, YC; Lien, RI; Lin, TY | 1 |
| Aguilar, J; Almela, M; Balasso, V; López, F; Marco, F; Martínez, JA; Mensa, J; Pozo, L; Soriano, A | 1 |
| Bratu, S; Brooks, S; Burney, S; Gupta, J; Kochar, S; Landman, D; Quale, J | 1 |
| Yoshida, A | 1 |
| Altindis, M; Caylan, R; Demirdağ, K; Günaydin, M; Gündes, S; Hoşoğlu, S; Karadenizli, A; Kolayli, F; Ucmak, H | 1 |
| Ip, M; Kei, HW; Lau, WC; Lee, N; Marasinghe, T; Wong, KY; You, JH | 1 |
| Ko, WC; Liu, YF; Tsai, SH; Wu, JJ; Yan, JJ | 1 |
| Gülmez, D; Hascelik, G; Kocagoz, S; Livermore, DM; Metan, G; Mushtaq, S; Palepou, MF; Uzun, O; Woodford, N; Yakupogullari, Y | 1 |
| Edwards, JR; Nairn, K; Shepherd, GL | 1 |
| Bradford, PA; Bush, K; Mariano, N; Projan, SJ; Rahal, JJ; Urban, C | 1 |
| Bitha, P; Li, Z; Lin, YI | 1 |
| Jeong, HJ; Kim, BJ; Kim, EJ; Kim, JH; Kwak, HJ; Lee, CH; Pyun, DK | 1 |
| Hayasaki, Y; Hua, YX; Izumi, K; Mikamo, H; Sato, Y; Tamaya, T | 1 |
| Iwatsubo, E; Kawakami, Y; Manabe, N; Matsumoto, T; Takahashi, K | 1 |
| Fung-Tomc, J; Mastalerz, H; Menard, M; Ruediger, E | 1 |
| Hopkins, JA; Lami, JL; Wilson, SE | 1 |
| Basker, MJ; Corbett, DF; Coulton, S; Southgate, R | 1 |
| Dworkin, RJ; Kennedy, SL; Sachdeva, M; Sande, MA; Tureen, JH | 1 |
| Edwards, JR; Nairn, K; Williams, S | 1 |
| Inouye, S; Ito, T; Kazuno, Y; Murata, S; Shomura, T; Yoshida, T | 1 |
8 review(s) available for carbapenems and E coli Infections
| Article | Year |
|---|---|
Antimicrobial resistance and molecular epidemiology of carbapenem-resistant Escherichia coli from urinary tract infections in Shandong, China.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Escherichia coli Infections; Humans; Molecular Epidemiology; Phylogeny; Urinary Tract Infections; Uropathogenic Escherichia coli | 2023 |
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Carbapenem and colistin resistance in Enterobacteriaceae in Southeast Asia: Review and mapping of emerging and overlapping challenges.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asia, Southeastern; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Child, Preschool; Colistin; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Genotype; Humans; Infant; Infant, Newborn; Klebsiella Infections; Male; Middle Aged; Young Adult | 2019 |
Escherichia coli sequence type 131: epidemiology and challenges in treatment.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; United States | 2014 |
Addressing the challenge of extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Urinary Tract Infections | 2009 |
Extended-spectrum beta-lactamase-producing bacterial infections in adult solid organ transplant recipients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Carbapenems; Escherichia coli Infections; Female; Gram-Negative Bacteria; Humans; Kidney Transplantation; Klebsiella Infections; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pancreas Transplantation; Recurrence; Retrospective Studies; Time Factors; Treatment Outcome | 2011 |
[Attention-getting cross infections: Extended-spectrum beta-lactamase-producing bacterial infections].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Proteus; Proteus Infections | 2007 |
5 trial(s) available for carbapenems and E coli Infections
| Article | Year |
|---|---|
Comparison of the Treatment Outcome of Piperacillin-Tazobactam versus Carbapenems for Patients with Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli in Areas with Low Frequency of Coproduction of OXA-1: a Preliminary Analysis.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Piperacillin, Tazobactam Drug Combination; Treatment Outcome | 2022 |
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
A PROspective study on the Usage patterns of Doripenem in the Asia-Pacific region (PROUD study).
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asia; Carbapenems; Doripenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Intensive Care Units; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome; Urinary Tract Infections; Young Adult | 2014 |
Adjunctive antimicrobials in surgery of soft tissue infections: evaluation of cephalosporins and carbapenems.
Topics: Adult; Aged; Bacterial Infections; Carbapenems; Cefmetazole; Cefoperazone; Cefotetan; Cefoxitin; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Remission Induction; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections; Thienamycins | 1991 |
235 other study(ies) available for carbapenems and E coli Infections
| Article | Year |
|---|---|
Complete Genetic Analysis of Plasmids Carried by Two Nonclonal
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Chickens; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Foodborne Diseases; Gene Transfer, Horizontal; Genome, Bacterial; Humans; Meat; Microbial Sensitivity Tests; Plasmids; Whole Genome Sequencing | 2021 |
In-vitro activity of fosfomycin against
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Spread of ESC-, carbapenem- and colistin-resistant Escherichia coli clones and plasmids within and between food workers in Lebanon.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Clone Cells; Colistin; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Lebanon; Microbial Sensitivity Tests; Plasmids | 2021 |
Genetic characterization of Carbapenem-Resistant Escherichia coli from China, 2015-2017.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Whole Genome Sequencing | 2021 |
Characterization of Escherichia coli strains resistant to carbapenems isolated from rectal swab in a multidrug-resistant strains screening programme.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Phylogeny; Plasmids | 2021 |
Trends in antimicrobial resistance in bloodstream infections at a large tertiary-care hospital in China: a 10-year retrospective study (2010-2019).
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies; Tertiary Care Centers | 2022 |
Cefmetazole as an Alternative to Carbapenems Against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Infections Based on In Vitro and In Vivo Pharmacokinetics/Pharmacodynamics Experiments.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefmetazole; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Mice; Microbial Sensitivity Tests; Neutropenia | 2021 |
Genomic characterisation of Escherichia coli isolates co-producing NDM-5 and OXA-1 from hospitalised patients with invasive infections.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Genomics; Humans; Microbial Sensitivity Tests | 2022 |
Genomic characterization of high-risk Escherichia coli and Enterobacter hormaechei clones recovered from a single tertiary-care hospital in Pakistan.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clone Cells; Disinfectants; Enterobacter; Escherichia coli; Escherichia coli Infections; Humans; Male; Microbial Sensitivity Tests; Pakistan; Plasmids; Tertiary Care Centers | 2022 |
A Natural Novel Mutation in the
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Mutation; Promoter Regions, Genetic | 2022 |
Correlation between antibiotic consumption and the occurrence of multidrug-resistant organisms in a Malaysian tertiary hospital: a 3-year observational study.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Inappropriate Prescribing; Klebsiella; Klebsiella Infections; Malaysia; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Tertiary Care Centers | 2022 |
First identification of
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; HIV Infections; Humans; Infant, Newborn; Microbial Sensitivity Tests; Plasmids; Tanzania | 2022 |
Vancomycin-arginine (STM-001) abrogates ESBL carrier and carbapenem-resistant Escherichia coli burden in a murine complicated urinary tract infection model.
Topics: Animals; Anti-Bacterial Agents; Arginine; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Chromatography, Liquid; Escherichia coli; Escherichia coli Infections; Mice; Microbial Sensitivity Tests; Tandem Mass Spectrometry; Urinary Tract Infections; Vancomycin | 2022 |
Hospital outbreak of carbapenem-resistant Enterobacterales associated with a
Topics: beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella pneumoniae; Plasmids | 2022 |
Dissemination of
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Plasmids | 2022 |
Biofilm and Gene Expression Characteristics of the Carbapenem-Resistant Enterobacterales,
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Gene Expression; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Association between gut microbiome and metabolome in mice suffering from acute carbapenem-resistant Escherichia coli infection.
Topics: Animals; Carbapenems; Escherichia coli; Escherichia coli Infections; Feces; Gastrointestinal Microbiome; Metabolome; Mice; RNA, Ribosomal, 16S | 2022 |
Different Effects of Antibiotics on
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Quinolones; Retrospective Studies | 2022 |
Pharmacodynamic evaluation of piperacillin/tazobactam versus meropenem against extended-spectrum β-lactamase-producing and non-producing Escherichia coli clinical isolates in a hollow-fibre infection model.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2022 |
Phylogroup typing and carbapenem resistance of
Topics: Animals; Carbapenems; Escherichia coli; Escherichia coli Infections; Feces; Philippines; Phylogeny | 2022 |
Role of Chromosome- and/or Plasmid-Located
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Chromosomes; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Microbial Sensitivity Tests; Plasmids | 2022 |
High-risk lineages among extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in Maputo Central Hospital, Mozambique.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Extraintestinal Pathogenic Escherichia coli; Gentamicins; Hospitals; Humans; Iron; Mozambique; Piperacillin; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Cefoxitin-based combination for ESBL-producing Enterobacteriaceae endocarditis.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoxitin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Endocarditis; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Urinary Tract Infections | 2022 |
Human Cell-Camouflaged Nanomagnetic Scavengers Restore Immune Homeostasis in a Rodent Model with Bacteremia.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; COVID-19 Drug Treatment; Cytokines; Endotoxins; Escherichia coli; Escherichia coli Infections; Glycophorins; Homeostasis; Humans; Microbial Sensitivity Tests; Opsonin Proteins; Rats; Receptors, Complement; Rodentia; SARS-CoV-2; Viral Envelope Proteins | 2022 |
Dynamic antimicrobial resistant patterns of Escherichia coli from healthy poultry and swine over 10 years in Chongming Island, Shanghai.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Penicillins; Polymyxins; Poultry; Sulfonamides; Swine; Tetracyclines | 2022 |
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; United States; Urinary Tract Infections | 2022 |
Drug resistance characteristics and molecular typing of Escherichia coli isolates from neonates in class A tertiary hospitals: A multicentre study across China.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Cefotaxime; Child; Ciprofloxacin; Doxycycline; Drug Resistance; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant, Newborn; Microbial Sensitivity Tests; Multilocus Sequence Typing; Piperacillin; Pregnancy; Tazobactam; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Escherichia coli resistance patterns, empiric and targeted antibiotic prescriptions in children: a single center experience.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Child; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Humans; Infant; Microbial Sensitivity Tests; Prescriptions; Retrospective Studies | 2022 |
Whole-Genome Sequence Analysis of Carbapenem-Heteroresistant Klebsiella pneumoniae and Escherichia coli Isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2022 |
Emergence of coexistence of a novel bla
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Plasmids | 2022 |
Genome Assessment of Carbapenem- and Colistin-Resistant
Topics: Animals; beta-Lactamases; Carbapenems; Colistin; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Hospitals; Microbial Sensitivity Tests; Plasmids | 2022 |
High prevalence of Escherichia coli co-harboring conjugative plasmids with colistin- and carbapenem resistance genes in a wastewater treatment plant in China.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Plasmids; Prevalence | 2023 |
High mortality risk of type III monomicrobial gram-negative necrotizing fasciitis: The role of extraintestinal pathogenic Escherichia coli (ExPEC) and Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Carbapenems; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fasciitis, Necrotizing; Humans; Klebsiella pneumoniae; Streptococcal Infections | 2023 |
Characterization of an International High-Risk Escherichia coli ST410 Clone Coproducing NDM-5 and OXA-181 in a Food Market in China.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Phylogeny; Plasmids | 2023 |
Exchange of Carbapenem-Resistant Escherichia coli Sequence Type 38 Intercontinentally and among Wild Bird, Human, and Environmental Niches.
Topics: Animals; Animals, Wild; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Birds; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Charadriiformes; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests | 2023 |
[Investigation of O25b-ST131 Clone Frequency and Presence of Carbapenem and Fosfomycin Resistance Genes in Escherichia coli Isolates: First Detection of fosA3 from Escherichia coli O25bSTf131 Clone from Türkiye].
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clone Cells; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Fosfomycin; Humans; Microbial Sensitivity Tests | 2023 |
A multicentre study to determine the
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Malaysia | 2023 |
Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Child, Preschool; Clone Cells; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Hospitals, University; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Plasmids; Quinolones; Yemen | 2020 |
Variable performance of different commercial systems for testing carbapenem susceptibility of KPC carbapenemase-producing Escherichia coli.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Diagnostic Errors; Ertapenem; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Molecular Typing; Random Amplified Polymorphic DNA Technique | 2019 |
AcrAB-TolC efflux pump system plays a role in carbapenem non-susceptibility in Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier Proteins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; India; Microbial Sensitivity Tests; Tertiary Care Centers; Transcription, Genetic | 2019 |
Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase-producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoxitin; Escherichia coli; Escherichia coli Infections; Fever; Humans; Male; Middle Aged; Propensity Score; Retrospective Studies; Urinary Tract Infections | 2020 |
Emergence and transmission of New Delhi metallo-beta-lactamase-5-producing Escherichia coli Sequence Type 361 in a Tertiary Hospital in South Korea.
Topics: Aged; Aged, 80 and over; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Republic of Korea; Tertiary Care Centers | 2020 |
Faropenem resistance causes in vitro cross-resistance to carbapenems in ESBL-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Porins | 2020 |
Isoalantolactone restores the sensitivity of gram-negative Enterobacteriaceae carrying MCR-1 to carbapenems.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Polymyxin B; Sesquiterpenes | 2020 |
New Delhi Metallo-β-Lactamase-5-Producing Escherichia coli in Companion Animals, United States.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cat Diseases; Cats; Dog Diseases; Dogs; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Microbial Sensitivity Tests; Records; Retrospective Studies; United States | 2020 |
First Indian report on genome-wide comparison of multidrug-resistant Escherichia coli from blood stream infections.
Topics: Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Genomics; Humans; India; Polymorphism, Single Nucleotide; Virulence; Whole Genome Sequencing | 2020 |
Transcriptional response of mar, sox and rob regulon against concentration gradient carbapenem stress within Escherichia coli isolated from hospital acquired infection.
Topics: Carbapenems; Cross Infection; DNA-Binding Proteins; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; India; Regulon; Trans-Activators | 2020 |
Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Saudi Arabia; Young Adult | 2020 |
Identification of an extensively drug-resistant Escherichia coli clinical strain harboring mcr-1 and bla
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Escherichia coli Proteins; Extraintestinal Pathogenic Escherichia coli; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Plasmids; Republic of Korea; Whole Genome Sequencing | 2020 |
Challenges in the nursing care of intracranial carbapenem-resistant Escherichia coli infection after severe traumatic brain injury: a case report.
Topics: Brain Injuries, Traumatic; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Intracranial Hypertension | 2020 |
The occurrence of Salmonella, extended-spectrum β-lactamase producing Escherichia coli and carbapenem resistant non-fermenting Gram-negative bacteria in a backyard poultry flock environment.
Topics: Aged; Animal Husbandry; Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Chickens; Child, Preschool; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Housing, Animal; Humans; Salmonella; Salmonella Infections, Animal; Surveys and Questionnaires | 2020 |
Risk factors for fecal carriage of extended-spectrum beta-lactamase-producing and carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains among patients at hospital admission.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prospective Studies; Risk Factors; Turkey | 2021 |
Novel IncFII plasmid harbouring blaNDM-4 in a carbapenem-resistant Escherichia coli of pig origin, Italy.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Europe; Humans; Italy; Microbial Sensitivity Tests; Plasmids; Swine | 2020 |
Impact of reflex fosfomycin susceptibility testing on the utilization of carbapenems for definitive extended-spectrum β-lactamase Escherichia coli urinary tract infection treatment.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cohort Studies; Escherichia coli; Escherichia coli Infections; Female; Florida; Fosfomycin; Humans; Male; Microbial Sensitivity Tests; Pharmacy Service, Hospital; Retrospective Studies; Urinary Tract Infections | 2020 |
Cross-border emergence of clonal lineages of ST38 Escherichia coli producing the OXA-48-like carbapenemase OXA-244 in Germany and Switzerland.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Adhesion; Bacterial Proteins; beta-Lactamases; Carbapenems; Cell Line, Tumor; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Genome, Bacterial; Germany; HeLa Cells; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Switzerland; Whole Genome Sequencing | 2020 |
Clinical and molecular characteristics of carbapenem non-susceptible Escherichia coli: A nationwide survey from Oman.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Databases, Genetic; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Genes, Bacterial; Humans; Infant; Infant, Newborn; Male; Middle Aged; Oman; Plasmids; Virulence Factors; Young Adult | 2020 |
Resensitizing carbapenem- and colistin-resistant bacteria to antibiotics using auranofin.
Topics: Animals; Anti-Bacterial Agents; Auranofin; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests | 2020 |
Emergence of carbapenem-resistant ST131
Topics: Adult; Aged; Carbapenems; Child; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Germany; Humans; Middle Aged; Young Adult | 2020 |
Clinical syndromes and treatment location predict utility of carbapenem sparing therapies in ceftriaxone-non-susceptible Escherichia coli bloodstream infection.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Carbapenems; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Tazobactam | 2020 |
Geographical distribution of Enterobacterales with a carbapenemase IMP-6 phenotype and its association with antimicrobial use: An analysis using comprehensive national surveillance data on antimicrobial resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Japan; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Phenotype | 2020 |
Efficacy of loading dose colistin versus carbapenems for treatment of extended spectrum beta lactamase producing Enterobacteriaceae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cohort Studies; Colistin; Escherichia coli; Escherichia coli Infections; Female; Humans; Kaplan-Meier Estimate; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2021 |
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Netherlands; Plasmids | 2021 |
Detection of Extended-Spectrum Beta-Lactamase-Producing and Carbapenem-Resistant Bacteria from Mink Feces and Feed in the United States.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Feces; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mink; United States | 2021 |
Colonization with selected antibiotic resistant bacteria among a cohort of Sri Lankan university students.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cohort Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella; Klebsiella Infections; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Sri Lanka; Staphylococcal Infections; Students; Universities; Young Adult | 2021 |
A Transferable IncC-IncX3 Hybrid Plasmid Cocarrying
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Enterobacter aerogenes; Escherichia coli Infections; Humans; Klebsiella Infections; Microbial Sensitivity Tests; Plasmids; Tigecycline | 2021 |
Co-localization of carbapenem (blaOXA-162) and colistin (mcr-1) resistance genes on a transferable IncHI2 plasmid in Escherichia coli of chicken origin.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Chickens; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Microbial Sensitivity Tests; Plasmids; Poultry Diseases | 2021 |
Carbapenem resistance in a rural part of southern India:
Topics: beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; India; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests | 2016 |
Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; DNA, Bacterial; Electronic Health Records; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Incidence; Inpatients; Klebsiella Infections; Klebsiella pneumoniae; Male; Surveys and Questionnaires; Young Adult | 2017 |
Efficacy of non-carbapenem antibiotics for pediatric patients with first febrile urinary tract infection due to extended-spectrum beta-lactamase-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child, Preschool; Escherichia coli; Escherichia coli Infections; Female; Fever; Humans; Infant; Japan; Male; Retrospective Studies; Urinary Tract Infections | 2017 |
Impact of appropriateness of empiric therapy on outcomes in community-onset bacteremia by extended-spectrum-β-lactamase producing Escherichia coli and Klebisella pneumoniae definitively treated with carbapenems.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Inappropriate Prescribing; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies | 2017 |
First report of an Escherichia coli strain from swine carrying an OXA-181 carbapenemase and the colistin resistance determinant MCR-1.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Farms; Gene Transfer, Horizontal; Italy; Multilocus Sequence Typing; Plasmids; Swine | 2017 |
Expanding landscapes of the diversified mcr-1-bearing plasmid reservoirs.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; China; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fenoterol; Gene Deletion; Humans; Interspersed Repetitive Sequences; Plasmids; Replication Origin; Sequence Analysis, DNA; Swine | 2017 |
Characterization of Carbapenem-Resistant Escherichia coli Isolates Through the Whole-Genome Sequencing Analysis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Escherichia coli; Escherichia coli Infections; Gene Expression; Genome, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Serogroup; Whole Genome Sequencing | 2018 |
A Long-Term Study of the Diversity of OXA-48-Like Carbapenemase-Producing Bacterial Strains in Infected Patients and Carriers.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; DNA Fingerprinting; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; France; Gene Expression; Genetic Variation; Hospitals; Humans; Isoenzymes; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Plasmids | 2018 |
Clinical Characteristics of Bacteremia Caused by Extended-spectrum Beta-lactamase-producing Escherichia coli at a Tertiary Hospital.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Female; Humans; Japan; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2017 |
Genetic characterization of blaNDM-harboring plasmids in carbapenem-resistant Escherichia coli from Myanmar.
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Evolution, Molecular; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Myanmar; Phylogeny; Plasmids; Sequence Analysis, DNA | 2017 |
Case report of transient mcr-1-haboring Escherichia coli with concurrent Staphylococcus aureus bacteremia in Long Beach, California.
Topics: Bacteremia; California; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Plasmids; Staphylococcal Infections; Staphylococcus aureus | 2017 |
The use of cefepime as a carbapenem-sparing antibiotic for treating uncomplicated acute pyelonephritis caused by extended-spectrum β-lactamase producing Escherichia coli.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Male; Middle Aged; Pyelonephritis; Republic of Korea; Retrospective Studies; Risk Factors; Treatment Outcome | 2018 |
Plasmid-mediated mcr-1 in carbapenem-susceptible Escherichia coli ST156 causing a blood infection: an unnoticeable spread of colistin resistance in Brazil?
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Brazil; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Microbial Sensitivity Tests; Plasmids | 2017 |
New Delhi metallo-β-lactamase - type carbapenemases producing
Topics: beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Urinary Tract Infections | 2017 |
IncX3 Epidemic Plasmid Carrying
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Farms; Gene Expression; Plasmids; Replicon; Swine | 2018 |
Trends in Resistance to Extended-Spectrum Cephalosporins and Carbapenems among Escherichia coli and Klebsiella spp. Isolates in a District in Western India during 2004-2014.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Humans; India; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests | 2018 |
Molecular characterisation of bla
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Farms; Feces; Genotype; India; Microbial Sensitivity Tests; Multilocus Sequence Typing; Shiga Toxin; Shiga-Toxigenic Escherichia coli; Swine; Virulence | 2018 |
Distribution of extended-spectrum β-lactam, quinolone and carbapenem resistance genes, and genetic diversity among uropathogenic Escherichia coli isolates in Tehran, Iran.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Biofilms; Carbapenems; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Genetic Variation; Humans; Iran; Microbial Sensitivity Tests; Middle Aged; Pyelonephritis; Quinolones; Uropathogenic Escherichia coli; Virulence; Virulence Factors; Young Adult | 2018 |
Novel variant NDM-11 and other NDM-1 variants in multidrug-resistant Escherichia coli from South India.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Genetic Variation; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Snake Bites; Wound Infection | 2018 |
Dissemination of
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests; Plasmids | 2018 |
Detection of Antibiotic Resistance Determinants and Their Transmissibility among Clinically Isolated Carbapenem-Resistant Escherichia coli from South India.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Databases, Nucleic Acid; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; India; Male; Middle Aged; Polymerase Chain Reaction; Tertiary Care Centers; Young Adult | 2018 |
Carbapenem-susceptible Escherichia coli ST3901 carrying mcr-1 and bla
Topics: beta-Lactamases; Brazil; Carbapenems; Diabetic Foot; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Male; Middle Aged | 2018 |
A clinical isolate of Escherichia coli co-harbouring mcr-1 and blaNDM-5 in Japan.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child, Preschool; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Genotype; Humans; Japan; Male; Molecular Typing; Plasmids | 2018 |
Sharing more than friendship - transmission of NDM-5 ST167 and CTX-M-9 ST69
Topics: Animals; beta-Lactamases; Carbapenems; Dogs; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Finland; Friends; Humans; Multilocus Sequence Typing; Pets; Polymerase Chain Reaction; Whole Genome Sequencing | 2018 |
Antibiotic exposure elicits the emergence of colistin- and carbapenem-resistant Escherichia coli coharboring MCR-1 and NDM-5 in a patient.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids | 2018 |
Molecular and Phenotypic Study of Carbapenem Resistant E. coli.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests | 2018 |
Molecular characterization of Carbapenem resistant Escherichia coli recovered from a tertiary hospital in Lebanon.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans; Lebanon; Multilocus Sequence Typing; Phylogeny; Polymorphism, Single Nucleotide; Serotyping; Tertiary Care Centers; Virulence | 2018 |
Carbapenem-Sparing Therapy for Extended-Spectrum β-Lactamase-Producing E coli and Klebsiella pneumoniae Bloodstream Infection: The Search Continues.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2018 |
Extended-spectrum β-lactamase-producing E. coli septicemia among rectal carriers in the ICU.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Carrier State; Case-Control Studies; Cephalosporins; China; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Hospital Mortality; Hospitals; Humans; Intensive Care Units; Male; Middle Aged; Rectal Diseases; Retrospective Studies; Risk Factors | 2018 |
High carriage rate of mcr-1 and antimicrobial resistance profiles of mcr-1-positive Escherichia coli isolates in swine faecal samples collected from eighteen provinces in China.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Farms; Feces; Gene Transfer, Horizontal; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Swine; Swine Diseases; Tigecycline | 2018 |
Early emergence of OXA-181-producing Escherichia coli ST410 in China.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Male; Middle Aged; Multilocus Sequence Typing; Plasmids | 2018 |
Infections Caused by Extended-Spectrum
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Case-Control Studies; Escherichia coli; Escherichia coli Infections; Female; Humans; Lupus Erythematosus, Systemic; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Retrospective Studies; Risk Factors | 2018 |
Hidden Carbapenem Resistance in OXA-48 and Extended-Spectrum β-Lactamase-Positive
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Conjugation, Genetic; Croatia; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids | 2019 |
Emergence of a multidrug-resistant clinical isolate of Escherichia coli ST8499 strain producing NDM-13 carbapenemase in the Republic of Korea.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Plasmids; Republic of Korea | 2019 |
Epidemiology and antimicrobial susceptibility profiles of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichiacoli in China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Preschool; China; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Young Adult | 2019 |
Characterization of an NDM-5 carbapenemase-producing Escherichia coli ST156 isolate from a poultry farm in Zhejiang, China.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Farms; Genome, Bacterial; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Poultry; Virulence Factors | 2019 |
Molecular characterization of carbapenem-resistant Escherichia coli and Acinetobacter baumannii in the Lao People's Democratic Republic.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Laos; Male; Middle Aged; Public Health Surveillance | 2019 |
Rapid Increase in Carbapenemase-Producing Enterobacteriaceae in Retail Meat Driven by the Spread of the
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meat; Microbial Sensitivity Tests; Plasmids | 2019 |
Detection of NDM-19, a novel variant of the New Delhi metallo-β-lactamase with increased carbapenemase activity under zinc-limited conditions, in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Culture Media; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Mutation; Plasmids; Recombinant Proteins; Surgical Wound Infection; Switzerland; Zinc | 2019 |
The antimicrobial peptide thanatin disrupts the bacterial outer membrane and inactivates the NDM-1 metallo-β-lactamase.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Catalytic Domain; Cell Wall; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Human Umbilical Vein Endothelial Cells; Humans; Inhibitory Concentration 50; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Zinc | 2019 |
Alternatives to carbapenems in ESBL-producing Escherichia coli infections.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Membrane Proteins; Microbial Sensitivity Tests; Sequence Alignment; Sequence Homology, Nucleic Acid | 2013 |
[Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011)].
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Prevalence; Urinary Tract Infections; Urine | 2013 |
Identification and characterization of the first Escherichia coli strain carrying NDM-1 gene in China.
Topics: Aged; beta-Lactamases; Blotting, Southern; Carbapenems; China; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Polymerase Chain Reaction; Transformation, Bacterial | 2013 |
Verona integron-encoded metallo-β-lactamase 1 in Enterobacteria, Ontario, Canada.
Topics: Aged; Aged, 80 and over; Bacteremia; Bacterial Proteins; Bacteriuria; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Fatal Outcome; Female; Humans; Integrons; Male; Middle Aged; Multilocus Sequence Typing | 2013 |
Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cluster Analysis; Conjugation, Genetic; DNA, Bacterial; Dogs; Escherichia coli; Escherichia coli Infections; Genotype; Germany; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing; Phylogeny; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA | 2013 |
Updated molecular epidemiology of carbapenem-non-susceptible Escherichia coli in Taiwan: first identification of KPC-2 or NDM-1-producing E. coli in Taiwan.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Multilocus Sequence Typing; Phylogeny; Taiwan | 2013 |
Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf cooperation council: dominance of OXA-48 and NDM producers.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle East; Oxytocin | 2014 |
Use of outpatient parenteral antimicrobial therapy for transrectal ultrasound-guided prostate biopsy prophylaxis in the setting of community-associated multidrug-resistant Escherichia coli rectal colonization.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Hospitalization; Humans; Image-Guided Biopsy; Infusions, Parenteral; Male; Middle Aged; Outpatients; Prevalence; Prospective Studies; Prostate; Prostatitis; Rectum; Ultrasonography, Interventional | 2014 |
Biochemical analysis of metallo-β-lactamase NDM-3 from a multidrug-resistant Escherichia coli strain isolated in Japan.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Japan; Microbial Sensitivity Tests; Plasmids | 2014 |
I read about infections from the so-called "superbugs." Is antibiotic resistance increasing?
Topics: beta-Lactam Resistance; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; United States | 2013 |
Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-β-lactamase-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefoxitin; Drug Administration Schedule; Drug Dosage Calculations; Escherichia coli; Escherichia coli Infections; Gene Expression; Humans; Microbial Sensitivity Tests; Models, Statistical; Pyelonephritis; Urinary Tract Infections | 2014 |
Risk factors for the acquisition of carbapenem-resistant Escherichia coli at a tertiary care center in South Korea: a matched case-control study.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Republic of Korea; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2014 |
Complete sequencing of IncI1 sequence type 2 plasmid pJIE512b indicates mobilization of blaCMY-2 from an IncA/C plasmid.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Citrobacter freundii; Conjugation, Genetic; Escherichia coli; Escherichia coli Infections; Humans; Interspersed Repetitive Sequences; Microbial Sensitivity Tests; Molecular Sequence Data; Phosphoproteins; Plasmids; Sequence Alignment | 2014 |
The determination of carbapenem resistance in Escherichia coli and Pneumoniae isolates related to nosocomial infections and the evaluation of risk factors.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Risk Factors | 2014 |
Detection of carbapenem resistance genes and cephalosporin, and quinolone resistance genes along with oqxAB gene in Escherichia coli in hospital wastewater: a matter of concern.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Molecular Sequence Data; Phylogeny; Quinolones; Wastewater | 2014 |
Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Escherichia coli Infections; Female; Hospitals; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Survival Analysis; Taiwan | 2015 |
Unexpected in vivo activity of ceftazidime alone and in combination with avibactam against New Delhi metallo-β-lactamase-producing Enterobacteriaceae in a murine thigh infection model.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Ceftazidime; Disease Models, Animal; Drug Combinations; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests | 2014 |
Efforts mount to curb carbapenem-resistant infections.
Topics: Carbapenems; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Bacterial; Escherichia coli Infections; Humans; Infection Control; Klebsiella Infections; Practice Guidelines as Topic; United States | 2014 |
A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cohort Studies; Critical Illness; Cross Infection; Decision Support Techniques; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis; Risk Factors; Surgical Procedures, Operative; Systemic Inflammatory Response Syndrome; Urinary Tract Infections | 2014 |
Complete Sequence of Four Multidrug-Resistant MOBQ1 Plasmids Harboring blaGES-5 Isolated from Escherichia coli and Serratia marcescens Persisting in a Hospital in Canada.
Topics: Aged; Aged, 80 and over; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Canada; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Endodeoxyribonucleases; Escherichia coli; Escherichia coli Infections; Female; Gene Expression Regulation, Bacterial; Genome, Bacterial; Hospitals; Humans; Interspersed Repetitive Sequences; Male; Middle Aged; Molecular Sequence Data; Phylogeny; Plasmids; Replicon; Sequence Alignment; Sequence Analysis, DNA; Serratia Infections; Serratia marcescens | 2015 |
Detection of OXA-48-like carbapenemase genes by the Xpert® Carba-R test: room for improvement.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Carrier State; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Genetic Variation; Humans; Male; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Sensitivity and Specificity | 2015 |
Transmission of carbapenem-resistant Enterobacteriaceae during ERCP: time to revisit the current reprocessing guidelines.
Topics: Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cholangiopancreatography, Endoscopic Retrograde; Cross Infection; Disinfection; Duodenoscopes; Equipment Contamination; Escherichia coli; Escherichia coli Infections; Female; Guidelines as Topic; Humans; Male; Middle Aged; Young Adult | 2015 |
Impact of carbapenem heteroresistance among clinical isolates of invasive Escherichia coli in Chongqing, southwestern China.
Topics: Aged; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Case-Control Studies; China; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Genetic Variation; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Prevalence; Risk Factors | 2015 |
Clinical Impact of Discordant Prescribing of Fluoroquinolones and Alternative Treatments in Escherichia coli Pyelonephritis.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Fluoroquinolones; Guidelines as Topic; Humans; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyelonephritis; Retrospective Studies; Treatment Outcome | 2016 |
Endoscopic retrograde cholangiopancreatography-associated AmpC Escherichia coli outbreak.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporin Resistance; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Disease Outbreaks; Duodenoscopes; Equipment Contamination; Escherichia coli; Escherichia coli Infections; Female; Humans; Infection Control; Male; Microbial Sensitivity Tests; Middle Aged | 2015 |
ERCP scopes: what can we do to prevent infections?
Topics: Carbapenems; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Disease Outbreaks; Duodenoscopes; Equipment Contamination; Escherichia coli; Escherichia coli Infections; Female; Humans; Infection Control; Male | 2015 |
[Evaluation of Antibiotics for the Treatment of Bacteremia Due to Extended-spectrum β-Lactamase-producing Escherichia coli].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cefmetazole; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk; Treatment Outcome; Young Adult | 2015 |
Characterization of Multidrug Resistant Extended-Spectrum Beta-Lactamase-Producing Escherichia coli among Uropathogens of Pediatrics in North of Iran.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Iran; Male; Urinary Tract Infections | 2015 |
Prevalence study on carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates in Czech hospitals--results from Czech Part of European Survey on Carbapenemase--Producing Enterobacteriaceae (EuSCAPE).
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Czech Republic; Escherichia coli; Escherichia coli Infections; Geography; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Prevalence; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Ukraine | 2015 |
Cefoxitin as a carbapenem-sparing antibiotic for infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoxitin; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome; Young Adult | 2015 |
Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. isolates in Mongolia.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mongolia; Plasmids; Polymerase Chain Reaction | 2016 |
Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) infections: are carbapenem alternatives achievable in daily practice?
Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cohort Studies; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Young Adult | 2015 |
Comparative effectiveness of flomoxef versus carbapenems in the treatment of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae with emphasis on minimum inhibitory concentration of flomoxef: a retrospectiv
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2015 |
In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefepime; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Male; Microbial Sensitivity Tests; Molecular Docking Simulation | 2015 |
Fluoroquinolone therapy for bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2017 |
Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Pyelonephritis; Republic of Korea; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Uropathogenic Escherichia coli | 2015 |
Association of Risk Factors, Antimicrobial Resistance Trends and Occurrence of blaTEM, bla SHV and blaCTX M in Escherichia coli Causing Bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Diabetes Complications; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Phenotype; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Urinary Tract Infections | 2016 |
Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Tablets | 2016 |
[Clinical features and antibiotic resistance of Escherichia coli bloodstream infections in children].
Topics: Adolescent; Bacteremia; beta-Lactamases; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Infant, Newborn; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Pneumonia; Urinary Tract Infections | 2016 |
First Description of IncX3 Plasmids Carrying blaOXA-181 in Escherichia coli Clinical Isolates in Burkina Faso.
Topics: Aged; beta-Lactamases; Burkina Faso; Carbapenems; Child; Child, Preschool; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Male; Microbial Sensitivity Tests; Plasmids; Young Adult | 2016 |
Severe Bloodstream Infection due to KPC-Producer E coli in a Renal Transplant Recipient Treated With the Double-Carbapenem Regimen and Analysis of In Vitro Synergy Testing: A Case Report.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Kidney Transplantation; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Middle Aged; Surgical Wound Infection; Thienamycins | 2016 |
Fecal Carriage of Extended-Spectrum β-Lactamases in Healthy Humans, Poultry, and Wild Birds in León, Nicaragua-A Shared Pool of bla
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Clone Cells; Columbidae; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Falconiformes; Feces; Gene Expression Regulation, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Nicaragua; Poultry; Sequence Analysis, DNA | 2016 |
High-level carbapenem-resistant OXA-48-producing Klebsiella pneumoniae with a novel OmpK36 variant and low-level, carbapenem-resistant, non-porin-deficient, OXA-181-producing Escherichia coli from Thailand.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fatal Outcome; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Typing; Porins; Thailand; Young Adult | 2016 |
blaNDM-5-carrying IncX3 plasmid in Escherichia coli ST1284 isolated from raw milk collected in a dairy farm in Algeria.
Topics: Algeria; Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Escherichia coli; Escherichia coli Infections; Farms; Milk; Plasmids; Raw Foods | 2016 |
[The clinical characteristics analysis of Escherichia coli bloodstream infection].
Topics: Bacteremia; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors | 2016 |
More Furious Than Ever: Escherichia coli-Acquired Co-resistance Toward Colistin and Carbapenems.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Microbial Sensitivity Tests; Plasmids | 2016 |
Colistin- and Carbapenem-Resistant Escherichia coli Harboring mcr-1 and blaNDM-5, Causing a Complicated Urinary Tract Infection in a Patient from the United States.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Male; Plasmids; Sequence Analysis, DNA; Sequence Homology; Travel; United States; Urinary Tract Infections; Urine | 2016 |
IncFII Conjugative Plasmid-Mediated Transmission of blaNDM-1 Elements among Animal-Borne Escherichia coli Strains.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Gene Expression; Plasmids; Prevalence; Swine; Swine Diseases | 2017 |
Various Sequence Types of Escherichia coli Isolates Coharboring
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Gene Transfer, Horizontal; Genetic Fitness; Genotype; Plasmids; Swine; Swine Diseases | 2017 |
OXA-48-producing ST372 Escherichia coli in a French dog.
Topics: Animals; beta-Lactamases; Carbapenems; Cats; Cephalosporins; Dogs; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins | 2017 |
Isolation of Escherichia coli ST131 producing KPC-2 in Bulgaria.
Topics: Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Bulgaria; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cefotaxime; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Microbial Sensitivity Tests; Phylogeny; Plasmids | 2017 |
Strain-specific transmission in an outbreak of ESBL-producing Enterobacteriaceae in the hemato-oncology care unit: a cohort study.
Topics: Adult; Aged; beta-Lactamases; Carbapenems; Cohort Studies; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Hospital Units; Humans; Japan; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Polymerase Chain Reaction; Young Adult | 2017 |
Risk factors and medical costs for healthcare-associated carbapenem-resistant Escherichia coli infection among hospitalized patients in a Chinese teaching hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Case-Control Studies; Catheterization, Central Venous; Child; Child, Preschool; China; Cross Infection; Drug Costs; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Health Care Costs; Hemoglobins; Hospitals, Teaching; Humans; Hyperglycemia; Incidence; Infant; Infant, Newborn; Length of Stay; Logistic Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Tertiary Care Centers; Tracheostomy; Urologic Diseases; Young Adult | 2017 |
Prospective study analyzing risk factors and characteristics of healthcare-associated infections in a Urology ward.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catheters, Indwelling; Cross Infection; Cystectomy; Drug Resistance, Microbial; Enterococcus; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Hospital Units; Humans; Immunosuppression Therapy; Incidence; Klebsiella; Klebsiella Infections; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Surgical Wound Infection; Urinary Catheters; Urinary Tract Infections; Urology; Vancomycin | 2017 |
Occurrence of bla
Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Conjugation, Genetic; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; India; Plasmids | 2017 |
Occurrence of bla
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gene Expression Regulation, Bacterial; Gene Transfer, Horizontal; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Tertiary Care Centers; Transcription, Genetic | 2017 |
Characterization of NDM-7 Carbapenemase-Producing Escherichia coli Isolates in the Arabian Peninsula.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Gene Expression; Humans; Kuwait; Microbial Sensitivity Tests; Minocycline; Multilocus Sequence Typing; Oman; Phylogeny; Plasmids; Saudi Arabia; Tigecycline; United Arab Emirates | 2017 |
Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Critical Care; Doripenem; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Genotype; Humans; Imipenem; Klebsiella; Klebsiella Infections; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Thienamycins; United States | 2017 |
Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.
Topics: Anti-Infective Agents; beta-Lactamases; Carbapenems; Cross Infection; Cross-Sectional Studies; Escherichia coli; Escherichia coli Infections; Female; Hospitals, Teaching; Humans; Incidence; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Sri Lanka; Urinary Tract Infections | 2017 |
High Carbapenem Resistance in Clinical Gram-Negative Pathogens Isolated in Egypt.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Egypt; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Gene Expression; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Morganella morganii; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia Infections; Serratia marcescens | 2017 |
Coexistence of MCR-1 and NDM-9 in a clinical carbapenem-resistant Escherichia coli isolate.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans | 2017 |
Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Predictive Value of Tests | 2008 |
Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Odds Ratio; Risk Factors | 2008 |
Emergence of carbapenem-resistant Escherichia coli producing CMY-2-type AmpC beta-lactamase in Brazil.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fatal Outcome; Humans; Male; Microbial Sensitivity Tests; Middle Aged | 2008 |
Carbapenem-resistant Escherichia coli carrying the blaVIM-1 gene in the community.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Humans; Male | 2009 |
Klebsiella pneumoniae Carbapenemase-producing Enterobacteriaceae, Northeast Florida.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Florida; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2009 |
Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems us
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Microbial Viability; Minocycline; Models, Theoretical; Serum; Tigecycline | 2009 |
Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis.
Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sepsis; Shock, Septic | 2010 |
In vitro activities of fosfomycin and carbapenem combinations against carbapenem non-susceptible Escherichia coli and Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Drug Synergism; Escherichia coli; Escherichia coli Infections; Fosfomycin; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2010 |
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
Topics: Academic Medical Centers; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Israel; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Time Factors | 2010 |
In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin | 2010 |
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2010 |
Prevalence and characteristics of ertapenem-nonsusceptible Escherichia coli in a Taiwanese university hospital, 1999 to 2007.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporinase; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Porins; Taiwan | 2010 |
Global spread of New Delhi metallo-β-lactamase 1.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Netherlands; Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus aureus; Travel | 2010 |
Emergence of VIM-1 metallo-β-lactamase-producing Escherichia coli in a neonatal intensive care unit.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Female; Greece; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Plasmids; Polymerase Chain Reaction | 2011 |
Carbapenem versus fosfomycin tromethanol in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related complicated lower urinary tract infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Urinary Tract Infections; Young Adult | 2010 |
Novel genetic environment of the plasmid-mediated KPC-3 gene detected in Escherichia coli and Citrobacter freundii isolates from China.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Citrobacter freundii; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Isoelectric Focusing; Meropenem; Microbial Sensitivity Tests; Middle Aged; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Thienamycins | 2011 |
Efficacy of carbapenems against a metallo-β-lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model.
Topics: Abdominal Abscess; Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Humans; Male; Rabbits; Rodent Diseases; Treatment Outcome | 2011 |
New Delhi metallo-beta-lactamase from traveler returning to Canada.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Canada; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; India; Male; Microbial Sensitivity Tests; Prostatitis; Pyelonephritis; Travel; Urine | 2011 |
[Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2011 |
Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome | 2011 |
Risk factors and outcomes of carbapenem-nonsusceptible Escherichia coli bacteremia: a matched case-control study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Escherichia coli; Escherichia coli Infections; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Liver Diseases; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Regression Analysis; Risk Factors; Survival Analysis; Taiwan; Treatment Outcome; Uremia | 2011 |
Fluoroquinolone-resistant acute prostatitis requiring hospitalization after transrectal prostate biopsy: effect of previous fluoroquinolone use as prophylaxis or long-term treatment.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Biopsy; Carbapenems; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatitis; Retrospective Studies; Vancomycin | 2012 |
Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Hospitalization; Hospitals, University; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Risk Factors; Treatment Outcome; Young Adult | 2010 |
Molecular detection and epidemiology of extended-spectrum beta-lactamase genes prevalent in clinical isolates of Klebsiella pneumoniae and E coli from Trinidad and Tobago.
Topics: Aminoglycosides; beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Trinidad and Tobago | 2010 |
When carbapenem-hydrolyzing beta-lactamase Kpc meets Escherichia coli ST131 in France.
Topics: Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Female; France; Humans; Middle Aged; Multilocus Sequence Typing; Urine | 2011 |
Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy, Needle; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Humans; Incidence; Levofloxacin; Male; Middle Aged; Ofloxacin; Prevalence; Prostate; Prostatitis; Rectum | 2011 |
Incidence of fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli at a comprehensive cancer center in the United States.
Topics: Anti-Bacterial Agents; beta-Lactamases; Blood; Cancer Care Facilities; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Neoplasms; Neutropenia; Retrospective Studies; United States; Urine | 2011 |
A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom.
Topics: Adult; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Genetic Variation; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; United Kingdom | 2011 |
Identification of a plasmid-borne blaIMP-11 gene in clinical isolates of Escherichia coli and Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Escherichia coli; Escherichia coli Infections; Gene Transfer, Horizontal; Humans; Infant; Infant, Newborn; Integrons; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Plasmids; Sequence Analysis, DNA; Sequence Homology | 2012 |
First detection of blaIMI-2 gene in a clinical Escherichia coli strain.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sepsis; Sequence Analysis, DNA | 2012 |
Efficacy of doripenem against Escherichia coli and Klebsiella pneumoniae in experimental meningitis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Cefepime; Cephalosporins; Disease Models, Animal; Doripenem; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Meningitis, Bacterial; Rabbits; Treatment Outcome | 2012 |
Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Carbapenems; Cefoxitin; Ceftriaxone; Conjugation, Genetic; Disease Models, Animal; Drug Administration Schedule; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Kidney; Mice; Microbial Sensitivity Tests; Mutation Rate; Plasmids; Urinary Bladder; Urinary Tract Infections | 2012 |
Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 β-lactamase.
Topics: beta-Lactamases; Carbapenems; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Genes, Bacterial; Greece; Hospitals; Humans; Isoelectric Focusing; Klebsiella pneumoniae; Long-Term Care; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Skilled Nursing Facilities | 2012 |
High prevalence of CTX-M-15-producing O25b-ST131 Escherichia coli clone in Bulgarian hospitals.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Bulgaria; Carbapenems; Clone Cells; Escherichia coli; Escherichia coli Infections; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Phylogeny; Population Surveillance; Random Amplified Polymorphic DNA Technique | 2012 |
Prevalence and characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Escherichia coli from pediatric wards of a Malaysian hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Child, Preschool; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Humans; Infant; Integrases; Malaysia; Microbial Sensitivity Tests; Phylogeny; Prevalence; Tertiary Care Centers | 2012 |
High prevalence and molecular analysis of macrolide-nonsusceptible Moraxella catarrhalis isolated from nasopharynx of healthy children in China.
Topics: Anti-Bacterial Agents; Asymptomatic Diseases; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child, Preschool; China; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli Infections; Humans; Infant; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Mutation; Nasopharynx; Phylogeny; Prevalence; RNA, Ribosomal, 23S | 2012 |
A permission system for carbapenem use reduced incidence of drug-resistant bacteria and cost of antimicrobials at a general hospital in Japan.
Topics: Anti-Bacterial Agents; Carbapenems; Cost-Benefit Analysis; Drug Costs; Drug Resistance, Bacterial; Drug Utilization; Escherichia coli Infections; Feasibility Studies; Hospital Costs; Hospitals, General; Humans; Inappropriate Prescribing; Infection Control; Japan; Klebsiella Infections; Medical Order Entry Systems; Pharmacy Service, Hospital; Practice Patterns, Physicians'; Program Evaluation; Pseudomonas Infections; Retrospective Studies; Time Factors | 2012 |
Correlation between levofloxacin consumption and the incidence of nosocomial infections due to fluoroquinolone-resistant Escherichia coli.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2016 |
Detection of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae producing NDM-1 in Lebanon.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lebanon | 2012 |
Use of meropenem Adatabs dissolved in MacConkey agar for screening NDM-1 positive Enterobacteriaceae in faecal surveillance cultures.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Culture Media; Drug Stability; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Middle Aged; Thienamycins | 2012 |
Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit.
Topics: Aged; Antibiotic Prophylaxis; beta-Lactam Resistance; Carbapenems; Carrier State; Community-Acquired Infections; Cross Infection; Enterobacteriaceae Infections; Escherichia coli Infections; Female; France; Humans; Intensive Care Units; Male; Middle Aged; Multivariate Analysis; Prevalence; Prospective Studies; Risk Factors | 2012 |
KPC-9, a novel carbapenemase from clinical specimens in Israel.
Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Ceftazidime; Escherichia coli; Escherichia coli Infections; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids | 2012 |
Clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteremia in an area with high endemicity.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Endemic Diseases; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests | 2013 |
Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains containing New Delhi metallo-beta-lactamase isolated from two patients in Vietnam.
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Vietnam | 2013 |
Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multihospital study.
Topics: Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier State; Case-Control Studies; Chicago; Community-Acquired Infections; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multilocus Sequence Typing; Odds Ratio; Prevalence; Propensity Score; Rectum; Respiration, Artificial; Skilled Nursing Facilities | 2012 |
Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Ciprofloxacin; Contraindications; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Male; Middle Aged; Nitrofurantoin; Prevalence; Retrospective Studies; Treatment Failure; Treatment Outcome; Urinary Tract; Urinary Tract Infections; Young Adult | 2013 |
Extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella spp. in a Singapore hospital: clinical spectrum.
Topics: Aged; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged | 2004 |
Infections of cefotaxime-resistant and cefmetazole-susceptible Escherichia coli and Klebsiella pneumoniae in children.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheterization; Cefmetazole; Cefotaxime; Child; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Heart Defects, Congenital; Humans; Immunologic Deficiency Syndromes; Infant; Inpatients; Klebsiella Infections; Klebsiella pneumoniae; Male; Neoplasms; Premature Birth; Taiwan | 2005 |
Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Critical Care; Diabetes Complications; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Treatment Outcome | 2005 |
[The proper use of carbapenem examined by Monte Carlo simulation].
Topics: Carbapenems; Escherichia coli Infections; Humans; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |
Clinical features of nosocomial infections by extended-spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; Taiwan; Treatment Outcome | 2005 |
Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia.
Topics: Adult; Aged; Bacteremia; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella; Klebsiella Infections; Male; Middle Aged; Retrospective Studies; Risk Factors | 2006 |
Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Incidence; Male; Microbial Sensitivity Tests; New York City; Polymerase Chain Reaction; Population Surveillance | 2007 |
Extended-spectrum beta-lactamases in ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish hospitals.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Ceftazidime; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Turkey | 2007 |
Are beta-lactams related to higher morbidity and mortality in urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli?
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Escherichia coli; Escherichia coli Infections; Hong Kong; Humans; Retrospective Studies; Treatment Outcome; Urinary Tract Infections | 2008 |
Characterization of carbapenem-non-susceptible Escherichia coli isolates from a university hospital in Taiwan.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals, University; Humans; Taiwan | 2008 |
Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Porins; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Turkey | 2008 |
Efficacy of meropenem in experimental meningitis.
Topics: Ampicillin; Animals; Carbapenems; Ceftazidime; Ceftriaxone; Cephalosporins; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Drug Evaluation; Drug Resistance, Microbial; Escherichia coli Infections; Gentamicins; Guinea Pigs; Haemophilus Infections; Haemophilus influenzae; Listeriosis; Meningitis, Bacterial; Meropenem; Neisseria meningitidis; Penicillin G; Pneumococcal Infections; Thienamycins | 1995 |
Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.
Topics: Amino Acid Sequence; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; Blotting, Southern; Carbapenems; Disease Outbreaks; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Infant; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids | 1997 |
Convergent syntheses of oral THF 1beta-methylcarbapenems.
Topics: Animals; Bacteria; Carbapenems; Escherichia coli Infections; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Spectrometry, Mass, Fast Atom Bombardment; Staphylococcal Infections | 1999 |
Synthesis and antibacterial activity of 2alpha-functionalized 1beta-methylcarbapenems related to KR-21012.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Carbapenems; Drug Stability; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Streptococcal Infections; Structure-Activity Relationship; Survival Rate | 2000 |
In vitro and in vivo antibacterial activities of a new injectable carbapenem, S-4661, against gynaecological pathogens.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Doripenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Microbial Sensitivity Tests; Rats; Uterine Diseases | 2000 |
Urinary tract infection in neurogenic bladder.
Topics: Acute Disease; Anti-Infective Agents, Urinary; Carbapenems; Cephalosporins; Chronic Disease; Epididymitis; Escherichia coli Infections; Female; Fever; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Male; Prostatitis; Pseudomonas Infections; Pyelonephritis; Urinary Bladder; Urinary Bladder, Neurogenic; Urinary Catheterization; Urinary Tract Infections | 2001 |
Synthesis and antibacterial activity of some novel 6-methyl- and 6-propenyl-substituted carbapenems.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Carbapenems; Drug Stability; Escherichia coli Infections; Mice; Molecular Structure; Stereoisomerism; Structure-Activity Relationship | 1992 |
Synthesis and antibacterial activity of C-2 carboxyethenylthio-carbapenem derivatives.
Topics: Animals; Bacteria; Carbapenems; Chemical Phenomena; Chemistry; Culture Techniques; Drug Stability; Escherichia coli Infections; Humans; Kidney; Mice; Molecular Conformation; Molecular Structure; Staphylococcal Infections; Stereoisomerism | 1990 |
Evaluation of FCE 22101 in experimental meningitis caused by Escherichia coli and Streptococcus pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Blood Bactericidal Activity; Carbapenems; Ceftriaxone; Escherichia coli Infections; Imipenem; Meningitis; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillins; Rabbits | 1989 |
Therapeutic activity of meropenem in experimental infections.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Escherichia coli Infections; Guinea Pigs; Immunosuppression Therapy; Lung Diseases; Male; Meropenem; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Pseudomonas Infections; Respiratory Tract Infections; Thienamycins; Urinary Tract Infections | 1989 |
Therapeutic effect of SF-2103A, a novel carbapenem antibiotic, in combination with cefotaxime, cefoperazone and other cephalosporins.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefoperazone; Cefotaxime; Cephalosporins; Drug Stability; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Kinetics; Proteus Infections; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1986 |